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IV. Summary 
Chlamydiales are obligate intracellular gram-negative bacteria that have 
gained high medical relevance. These important human pathogens cause diverse 
diseases including trachoma and wide spread sexually transmitted diseases. 
Chlamydia establishes membrane bound inclusions in the host cell and loots the host 
for nutritional requirements. Infections are usually recognized by the host immune 
system and eliminated systematically, by triggering apoptosis. However, the pathogen 
Chlamydia has evolved various strategies to prevent the detection as well as protect 
the invaded cell against apoptosis or any other form of cell death. The evolutionary 
conservation of cell death regulation has not been investigated in the order 
Chlamydiales, which also includes Chlamydia-like organisms with a broader host 
spectrum. The present study was aimed at investigating the apoptotic response of 
human cells infected with the Chlamydia-like organism Simkania negevensis (Sn). 
Simkania infected cells exhibited strong resistance to apoptosis induced by 
intrinsic stress or by the activation of cell death receptors. Apoptotic signaling was 
blocked upstream of mitochondria since Bax translocation, Bax and Bak 
oligomerisation and cytochrome c release were absent in these cells. Caspases were 
differentially regulated upon Sn infection. Caspase-3 and -9 were not activated upon 
Sn infection and apoptosis induction; whereas caspases-8 was activated in Sn 
infected cells even without apoptosis induction. This indicates that, Sn utilizes death 
receptor association independent caspase activation for thriving in the host 
environment. Infected cells turned on pro-survival pathways like cellular Inhibitor of 
Apoptosis Proteins (IAP-1/2 and XIAP) and the Akt/PI3K pathway. Sn infection also 
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activated the pro-survival transcription factor NF-кB. Blocking any of these survival 
pathways sensitized the infected host cell towards apoptosis induction, demonstrating 
their role in infection-induced apoptosis resistance. The NF-кB mutant cells also 
showed reduced infectivity of Sn, which indicated an essential role of NF-кB in Sn 
infection.  
It was interesting to observe that, Acanthamoeba castellanii, a natural host of 
Sn, survived maintaining its trophozoite forms after infection with Sn upon starvation. 
The metacaspases, responsible for encystment could be regulated by Sn upon 
infection. This suggests an early level of gene regulation indicating how the pathogen 
evolved its ability to inhibit apoptosis in higher organisms.  
The resistance to apoptosis pathways subverted in Sn-infected cells was 
similar but not identical to those modulated by Chlamydia. Together, the data 
supports the hypothesis of evolutionary conserved signaling pathways to apoptosis 
resistance as common denominators in the order Chlamydiales. 
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V.  Zusammenfassung 
 
Vertreter der Ordnung Chlamydiales sind obligat intrazelluläre gram-negative 
Bakterien mit einer zunehmenden medizinischen Relevanz. Diese Humanpathogene 
lösen verschiedene Krankheiten aus, unter anderem Blindheit und sexuell 
übertragbare Krankheiten. Chlamydia führt zur Ausbildung einer Membran-
umschlossenen Inklusion innerhalb der Wirtszelle und entzieht dem Wirt die nötigen 
Nährstoffe. Infektionen können vom Immunsystem des Wirts erkannt und 
systematisch mittels Apoptose bekämpft werden. Chlamydia hat jedoch verschiedene 
Strategien entwickelt um der Erkennung durch das Immunsystem zu entgehen und 
um ihre Wirtszelle vor dem Zelltod zu schützen. Ob die Fähigkeit den Zelltod der 
Wirtszelle zu regulieren evolutionär innerhalb der Ordnung der Chlamydiales, welche 
auch Chlamydia-ähnliche Organismen mit einem breiteren Wirtsspektrum beinhalten,  
konserviert ist wurde bislang noch nicht untersucht. In dieser Arbeit wurde das 
apoptotische Verhalten humaner mit dem Chlamydia-ähnlichen Organismus Simkania 
negevensis (Sn) infizierter Zellen untersucht.  
Mit Simkanien infizierte Zellen zeigen eine starke Apoptose-Resistenz, 
unabhängig ob diese über intrinsischen Stress oder durch die Aktivierung von 
Todesrezeptoren ausgelöst wurde. Die Apoptose-Signalkaskade wurde vor den 
Mitochondrien blockiert, da es weder zu einer Bax Translokation, Bax und Bak 
Oligomerisierung  noch zur Cytochrom c Freisetzung in den infizierten Zellen kam. 
Auch Caspasen zeigten eine veränderte Regulation. Die Caspase-3 und -9 wurden 
während  einer Sn-Infektion und Apoptose-Induktion nicht aktiviert. Die Caspase 8 
jedoch ist während der Sn-Infektion unabhängig von einer Apoptose-Induktion aktiv. 
Diese Tatsache  lässt vermuten, dass Sn sich eines von den Todesrezeptoren 
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unabhängigen Mechanismus der Caspaseaktivierung bedienen um in der Wirtzelle zu 
verbleiben. Infizierte Zellen zeigen eine Aktivierung verschiedener antiapoptotischer 
Signalwege wie der der Inhibitor of Apoptotis Proteins (IAP1/2 and XIAP)- und den 
Akt/PI3K Signalweg. Durch eine Sn-Infektion kommt es außerdem zur Aktivierung 
des Transkriptionsfaktors NF-kB. Wird einer dieser Überlebenssignalwege blockiert 
zeigen die infizierten Wirtszellen eine erhöhte Sensitivität gegenüber einer 
Apoptoseinduktion, was wiederum die zentrale Rolle der infektionsvermittelten 
Apoptoseresistenz aufzeigt. Eine Zelllinie mit mutiertem NF-kB zeigte eine 
verminderte Infektiosität von Sn, was die zentrale Rolle von NF-kB in der Sn-Infektion  
unterstreicht.  
Infektionsversuche mit Sn und dessen natürlichem Wirt Acanthamoeba 
castellanii zeigten, dass diese im Sn-infizierten Stadium die Aufrechterhaltung ihrer 
Trophozyten-Form nach Nährstoffmangel überlebten. Die Metacaspasen, welche für 
die Einkapselung verantwortlich sind konnten durch eine Sn-Infektion reguliert 
werden. Dies weist auf ein frühes Stadium der Genregulation hin und lässt vermuten 
wie die Pathogene die Fähigkeit zur Apoptose-Inhibition höherer Organismen erlangt 
haben könnten. 
Die durch eine Sn-Infektion vermittelte Resistenz der Wirtszelle gegenüber 
Apoptose-Signalwegen ist ähnlich, jedoch nicht identisch zu der durch Chlamydia 
vermittelten Resistenz. Diese Ergebnisse unterstützen die Hypothese eines 
evolutionär konservierten Signalwegs der Apoptoseresistenz als allgemeiner Nenner 
in der Ordnung der Chlamydiales. 
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Introduction 
1.1. Chlamydiales 
The bacterial order Chlamydiales includes obligate intracellular bacteria that 
have a Chlamydia-like developmental cycle and at least 80% 16S rRNA or 23S rRNA 
gene sequence identity. They infect cells of vertebrates (causing relevant diseases) 
and amoebae, while similar particles have been reported in invertebrate species 
including coelenterates, arthropods and mollusks. 
1.1.1. History 
Chlamydia-like disease ‘trachoma’ has been described in ancient Chinese 
and Egyptian manuscripts. In 1907, Halberstaedter and von Prowazek took 
conjunctival scraping from infected individuals and inoculated into the eyes of orang-
utans (Fields and Barnes 1999). They named the new organism they found 
Chlamydozoa. Similar inclusions were subsequently described in the conjunctival 
cells of babies with non-gonococcal ophthalmia neonatorum in the uterine cervix from 
their mothers and in the urethral epithelium from male patients with non-gonococcal 
urethritis. These particles were capable of passing filters that retained most other 
bacteria. This property, coupled with the inability of these agents to grow on artificial 
media, led to the erroneous belief that these agents were viruses. Later in 1932 
similar particles were reported in birds with acute pneumonia, psittacosis (Rivers & 
Schwentker, 1932). The finding of a common complement-fixing antigen strengthened 
the idea that these agents are those of Lymphogranuloma venereum (LGV) and 
hence was first propagated in monkey brain. The term ‘Chlamydia’ (Gr. Chlamus, a 
cloak) appeared in the literature in 1945. In 1965 with the advent of tissue culture
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techniques and electron microscopy, evidence for bacterial rRNA, ribosomes and cell 
wall structures in Chlamydiae, it became evident that they were not viruses (Graham, 
1965). Thus these particles were set out for further studies and classification under 
the order Chlamydiales. 
1.1.2. Taxonomy  
For years, Chlamydiales was the only bacterial order that had just one family 
and one genus (the Chlamydiaceae and Chlamydia, respectively). In the 1990s, 
based on the divergence in the glycogen accumulation inside the inclusion (Gordon & 
Quan, 1965) and resistance towards sulfadiazine (Lin & Moulder, 1966) the family 
Chlamydiaceae contained two species, Chlamydia pneumoniae and Chlamydia 
pecorum [both now placed into the genus Chlamydophila]. New molecular diagnostic 
methods based on nucleic acid amplification led to Chlamydiae being discovered in 
tissues and cells never before reported (joints, atherosclerotic plaques, brains, 
amoebae) (Table 1.1) and associated with diseases of previously unknown etiology 
like reactive arthritis, Alzheimer's disease, coronary artery disease, etc led to the 
deposition of 40 more chlamydial strains in the American Type Culture Collection 
(ATCC). DNA-DNA re-association, in particular, was established as a tool for 
distinguishing species (70% homology) and genera (20%homology) (Amann et al, 
1995; Schleifer & Stackebrandt, 1983; Wayne & Diaz, 1987). Based on 16S and 23S 
ribosomal RNA sequence analyses and taking into account recently identified obligate 
intracellular species with Chlamydia-like developmental cycles, including Simkania 
negevensis (Kahane et al, 1995) and the amoebae isolate Parachlamydia 
acanthamoebae (Amann et al, 1997). With all this existing findings, Everett et al 
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(1999) made the new taxonomy of the order Chlamydiales which split the former 
family Chlamydiaceae into two genera, Chlamydia and Chlamydophila [the name 
Chlamydophila, given by Hans Truper and Johannes Storz, means 'chlamydia-like'], 
encompassing nine species, and added three new known Chlamydiaceae families, 
the Parachlamydiaceae, Waddliaceae and Simkaniaceae. Later (Schachter et al, 
2001) mentioned that as there is no sufficient sequence difference in the order 
Chlamydiales, a division of genus into Chlamydophila and Chlamydia is unnecessary. 
Hence a modified version of the phylogenetic tree of Chlamydiales is shown in Figure 
1.1. 
 
Figure 1.1: The phylogenetic tree of Chlamydiales. Based on the 16S and 23S ribosomal RNA 
sequence analysis, four families of Chlamydiales were classified with single genera in the family 
Chlamydiacea. Subsequently 16 species (many serovars not mentioned) identified are classified above 
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with the respective hosts. The length of the lines does not represent the phylogenetic distance 
(modified from (Everett et al, 1999)). The pathogen under study is depicted in red. 
(Modified after (Everett, 2000)) 
Table 1.1. List of different species in the genus Chlamydia, the specific hosts and the route of entry 
and site of infection. 
Species Host Route of entry 
C.muridarum Mouse, hamster Pharyngeal, genital 
C.suis Swine Pharyngeal 
C. trachomatis Human Pharyngeal, ocular, 
genital, rectal 
C. abortus Mammals Oral, genital 
C. caviae Guinea pig Pharyngeal, ocular, 
genital, urethral 
C. felis Cat Pharyngeal, ocular, 
genital 
C. pecorum Mammals Oral 
C. pneumoniae Human, frog, koala, 
horse 
Pharyngeal, ocular 
C. psittaci Birds Pharyngeal, ocular, 
genital 
S.negevensis Amoeba, human Pharyngeal 
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1.1.3. Pathogenicity and epidemiology of Simkania negevensis (Sn) 
Chlamydiae are obligate intracellular bacteria that cause a variety of acute 
and chronic diseases with high prevalence rate. The increase in reported chlamydial 
infections during the last 20 years reflects the expansion of clinical studies to 
understand better the virulence mechanism and the biology of the pathogen. 
Discovered recently, Simkania negevensis is another obligate intracellular 
bacterium, isolated as a cell culture contaminant of unknown origin (Kahane et al, 
1993). To date only one strain of Simkania, Z T (ATCC VR-1471T) (Everett et al, 1999) 
has been recognized. It has been suggested that Sn is an ubiquitous microorganism 
present in most aquatic habitats because of its relative resistance to commonly used 
procedures for routine treatment of drinking water supplies and its ability to replicate 
and exist in amoeba (Kahane et al, 1998). Later Simkania was reported as an 
emerging pathogen associated with several types of respiratory tract infection such as 
bronchiolitis in infants (Lieberman, Kahane et al. 1997; Kahane, Greenberg et al. 
1998; (Greenberg et al, 2003; Greub, 2009), community acquired pneumonia 
(Guttmacher et al, 1997; Heiskanen-Kosma et al, 2008; Nascimento-Carvalho et al, 
2009), chronic obstructive pulmonary disease in adults (Lieberman et al, 2002) and 
acute rejection in lung transplant recipients (Husain et al, 2007). Sn has also been 
amplified from an aortic aneurysm (Friedman et al, 2003). Moreover, seroprevalence 
rates in adults between 46–80% suggest a broad distribution of the organism in 
human populations (Lieberman et al, 1997). Sn has been suggested to represent a 
newly emerging pathogen because of its versatile infection capability (Friedman, 
Dvoskin et al. 2003; Kahane, Fruchter et al. 2007). 
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Simkania replicates in a biphasic life cycle similar to Chlamydia. Infection 
starts with an electron dense elementary body (0.2-0.3 μm), which differentiates into 
the electron lucent replicative form called the reticulate body (0.3-0.7 μm). The active 
replication cycle of Sn takes about 3–5 days and extensive long-term relationship with 
the host cell of about 10–15 days has been reported (Kahane et al, 2002). The 
strategy that this pathogen takes to keep its host alive for such a long period of time is 
unknown. Unlike other Chlamydiales (Kahane et al, 2002) observed that in Sn the 
replicative form may also be infective. This assumption was derived from the fact that 
they could observe similar kinetics of growth curve in less dense (RB) and more 
dense (EB)  urografin fractions.  
For decades research progress has been hampered to fully understand the 
genetics of Chlamydiales as they are obligate intracellular pathogens, there is no 
means to genetically manipulate them. Recently (Wang et al, 2011) had discovered 
that foreign DNA could be introduced into the chlamydial inclusion by using calcium 
ions. This will pave way for the chlamydial genetics and could lead to the 
development of chlamydial vaccines and therapeutic interventions. 
1.1.4. The chlamydial life style 
Chlamydiales have a unique biphasic life cycle. Bedson and colleagues first 
observed these distinct particles when they examined psittacosis-infected tissue 
(Bedson et al 1932). Later the existence of these developmental forms confirmed 
under electron microscopic studies (Constable, 1959; Gaylord, 1954). The pathogen 
exists in two morphological forms namely elementary body (EB), which is infective, 
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but metabolically inactive and reticulate body (RB), metabolically active and non-
infective. The EB is 0.3 µm in diameter and RB around 1 µm. Infection is initiated by 
adherence of EB to the host cells through an unknown receptor that probably binds 
with heparan sulfate-like glycosaminoglycan present on the cell surface (Gutierrez-
Martin et al, 1997; Kuo et al, 1973). Several other ligands for Chlamydia binding have 
also been proposed, including Hsp70 and Omp2 (Joseph & Bose, 1991; Raulston et 
al, 1998; Su et al, 1996; Swanson & Kuo, 1994; Ting et al, 1995). Recent studies 
further revealed the crucial role of the cellular PDGF-β receptor, the host kinase c-
Abl, and the chlamydial protein Tarp (translocated actin recruiting phosphoprotein) in 
pathogen uptake (Clifton et al, 2004; Elwell et al, 2008). Together with other 
chlamydial effector proteins Tarp is translocated into the host cell via a type III 
secretion system (T3SS), a needle-like protein complex that spans the bacterial 
membranes (Subtil et al, 2000). Cytoskeleton rearrangements induce the uptake of 
the EB, which can also be seen in non-phagocytic cell (Jewett et al, 2008). After 
binding, the Chlamydia is internalized, enveloped within membrane-bound 
compartments that are subjected to bacteria induced modifications both in their 
luminal environment and in their membrane composition, and transported to a 
perinuclear location. These modified Chlamydia-containing membrane compartments 
are termed inclusions. The bacteria appear to survive within the inclusion in host 
epithelial cells through their ability to inhibit fusion between the inclusions and 
lysosomes (Eissenberg et al, 1983; Scidmore et al, 1996a; Scidmore et al, 1996b) 
whereas the fusion to sphingomyelinrich vesicles is enhanced (Hackstadt et al, 1995).  
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Figure 1.2. Infectious EB adhere to the receptors on the host cell. Upon internalization, the chlamydial 
inclusion is formed where EB differentiate into RB, which replicate by binary fission to produce several 
hundred particles that re-differentiate into infectious EB which leave the cell in order to start a new 
round of infection. Under certain conditions, such as sub-lethal doses of antibiotics like penicillin, IFN-γ 
stimulation or co-infection with virus, aberrant bodies can be formed to persist inside the host cell. 
Depending on the species, the developmental cycle is completed after 48-72 h or 5-8 days in tissue 
culture cell lines. 
Within the inclusions, the EB differentiates into RB, which synthesize proteins 
and their own DNA and RNA then replicate by binary fission to form micro-colonies 
within the inclusion bodies. Differentiation of an EB into RB involves an increase in 
size, reduction of disulphide links in the outer membrane, unraveling of DNA in the 
condensed nucleoid and appearance of granular ribosomes (Wang et al, 1994). The 
initial signal for the differentiation of EB into RB is not known. By 18 hours post 
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infection (hpi), a proportion of the developed RB begins to transform back into EB 
while the remainder continues to divide in the growing inclusion (Hackstadt et al, 
1999) within 24 h large inclusions are formed. Between 24 and 72 hpi the RB re-
differentiate into EB and are released into the extracellular space by rupturing the 
cells to start a new round of infection (Moulder, 1991) as shown in Figure 1.2. As the 
RB is not infectious, re-differentiation into EB is an essential step in the chlamydial 
developmental cycle for the establishment of an acute infection. The engagement of 
the chlamydial type III secretion system in RB to EB re-differentiation was recently 
discussed by (Peters et al, 2007). The environmental signal that induces the 
reorganization from RB to EB is undefined. In the presence of Interferon γ, virus 
infection or antibiotics like penicillin the chlamydial particles gets stuck reversibly in 
the persistence stage where only aberrant bodies are observed. Persistence is the 
viable but non-cultivable growth stage of Chlamydia where it maintains long term 
relation with the host cells (Hogan et al, 2004). Depending on the species and the 
amount of bacteria that entered the cell, the developmental cycle of C. trachomatis, 
C. pneumonia and Simkania negevensis in cultured cell lines is completed after 48 h, 
72 h and 5 days, respectively. 
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Figure 1.3. Transmission electron micrograph of intracellular Chlamydia in membranous vacuoles of 
an infected cervical cancer cell. Black arrowheads indicate the condensed elementary bodies (EB) 
and multiplying reticulate bodies (RB). Bar-2μm 
1.2. Cell death: Evolution 
Cell death has historically been subdivided into regulated and unregulated 
mechanisms. It is a fundamental cellular response that has a crucial role in shaping 
our body during development and in regulating tissue homeostasis by eliminating 
unwanted cells. The first form of regulated or programmed cell death (PCD) to be 
characterized was apoptosis, which was described in Caenorhabitis elegans in the 
early 1990s (Horvitz et al, 1994). PCD was first defined as the active physiological 
process of cell death depending on signaling events in the dying cell (Lockshin & 
Williams, 1965). Later different types of PCDs were characterized, including the 
apoptosis (type I PCD) and autophagy (typeII PCD). 
Apoptosis reflects a cell's decision to die in response to cues and is executed 
by intrinsic cellular machinery. Apoptosis involves controlled and well organized 
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events leading to cell death, in contrast the uncontrolled cell death (necrosis) entails a 
rapid loss of membrane integrity and release of cellular components into the 
extracellular space which leads to damage of neighboring cells and elicitation of 
immune response (Wyllie et al, 1980). A comparatively young type of PCD is 
pyroptosis. It can be described as a combination of apoptosis and necrosis as it both 
displays apoptotic characteristics and provokes inflammation (Cookson & Brennan, 
2001). Due to its features resembling parts of necrosis, a fourth type of PCD has 
lately been proposed, termed pyronecrosis (Willingham, Bergstralh et al. 2007). 
Both the lack and excess of cell death are implicated in several relevant human 
diseases, including Alzheimer´s disease (Loo et al, 1993) and Huntington disease 
(Portera-Cailliau et al, 1995), autoimmune disorders and cancer (Fukuhara et al, 
1979; Tsujimoto et al, 1985) 
Emerging evidence, however, suggests that the above said types of cell 
death do not adequately explain the various cell death mechanisms observed. Recent 
data point to the existence of multiple non-apoptotic, regulated cell death 
mechanisms, some of which overlap or are mutually exclusive with apoptosis 
(Degterev & Yuan, 2008). In addition to serving the maintenance of the body, the 
immune system activates PCD to eliminate the infected cell from the organism. 
Hence it is not surprising that the microbial pathogens have evolved a variety of 
strategies to modulate host cell death and subvert normal host defense response 
(Best, 2008). 
1.2.1. Morphological and biochemical features of apoptosis 
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Apoptosis, the best characterized form of PCD, was coined by Kerr et al 
(1972) who termed this cellular phenomenon after the Greek saying 
“falling  off  leaves” (apo=off  and  ptosis=fall). Morphologically apoptosis is 
characterized by plasma membrane blebbing, cell body shrinkage (pyknosis), nuclear 
condensation and fragmentation (karyorrhexis), and formation of membrane bound 
cell fragments (apoptotic bodies). The apoptotic bodies consist of cytoplasm and 
tightly packed organelles enclosed within an intact plasma membranethat are rapidly 
phagocytosed invivo by neighboring cells and resident phagocytes. This helps to 
prevent any inflammatory response, as the cytoplasmic content is not spilled into the 
extracellular milieu and the engulfment of apoptotic cells may actively prevent the 
production of inflammatory cytokines by macrophages and suppress dendritic cell 
maturation and antigen presentation (Brown et al, 2002). Biochemical features of 
apoptosis include a decrease in mitochondrial inner transmembrane potential, the 
activation of selective proteases leading to restrictive hydrolysis of more than 400 
proteins, the cleavage of chromosomal DNA into internucleosomal fragments, the 
selective cleavage of various cellular proteins, and the translocation of 
phosphatidylserine from the inner to the outer leaflet of the plasma membrane 
(Salvesen and Riedl, 2008; Strasser et al., 2000). The main proteases involved in this 
extensive hydrolysis are members of caspase family (Chinnaiyan & Dixit, 1996) 
besides caspases, other proteases like lysosomal cathepsin, calpains and granzymes 
are also characterized in the apoptotic process (Lord et al, 2003). The specific 
morphological and biochemical features of apoptosis are manifestations of 
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evolutionarily conserved cell suicide machinery comprising of many apoptosis 
mediators described below.  
1.2.2. Apoptosis-The fundamental mechanism of PCD 
A simple pathway controls the primordial paradigm of PCD, described first in 
Caenorhabitis elegans. The initiation of apoptosis is regulated by transcriptional 
upregulation of Egl-1, a pro-apoptotic Bcl-2 homology-3 (BH3)-only member of the 
Bcl-2 protein family (Conradt & Xue, 2005). Binding of Egl-1 to anti- apoptotic CED-9 
relieves the inhibition that CED-9 exerts on the adaptor protein CED-4, allowing CED-
4 to bind and activate the cysteine protease CED-3, which in turn cleaves multiple 
specific cellular substrates to execute cell death (Metzstein et al, 1998) as described 
in Figure 1.4. Later, the mammalian homologues for the CED protein were revealed, 
though more complex, the mechanism seems to be highly conserved. 
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Figure 1.4. Comparison of cell death in C. elegans and mammalian cells. Extension of the apoptotic 
machinery can be observed at every step of the pathway, including BH3-only-protein activating signals, 
complex regulation of the Bcl-2 family and the addition of mitochondrial cytochrome c release, which 
drives the formation of an apoptosome and activation of the upstream caspases (first caspase-9 and 
then the executioner caspases, such as caspase-3 and caspase-7). Added complexity is provided by 
the existence of multiple family members in each class of the apoptotic regulators. These regulators 
provide 'fail-safe' apoptosis machinery that can generate specialized responses to various upstream 
stimuli. 
1.2.3. Caspases-The Major class of apoptosis mediators 
Caspases, the interleukin-1β-converting enzyme (ICE) is a family of cysteine 
proteases (Chinnaiyan & Dixit, 1996). They are highly homologues to CED-3 in C. 
elegans. Fourteen different caspases are identified so far in humans (Alnemri et al, 
1996), with three major functions, apoptosis activation, apoptosis execution and 
inflammatory mediation (Table 1.2). Caspases and their homologues are present in 
diverse species including nematodes, yeast and dipterans (Kumar & Doumanis, 
2000). 
The caspase family members share similarities in the amino acid sequence, 
structure and also the substrate specificity among each other (Nicholson & 
Thornberry, 1997). Caspases have an absolute requirement for cleavage after an 
aspartic acid in the substrate, but there is some exception to this rule that some 
caspases can cleave their substrate after a Glutamate (Hawkins et al, 2000). The 
protease activity of caspases is highly efficient, but not all proteins containing the 
tetrapeptide sequence X-Glu-X Asp are cleaved by caspases, implying that the 
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tertiary structural elements are also important for substrate recognition (Thornberry & 
Lazebnik, 1998). This strict substrate specificity explains why apoptosis does not 
entail indiscriminate protein digestion, but instead consists of cleavage of specific 
proteins in a coordinated fashion. 
 Caspases are synthesized as inactive zymogens in the cells and are 
activated either by autocatalytic processing by adaptor-protein mediated aggregation 
or by proteolysis by other active caspases (Thornberry & Lazebnik, 1998). Caspases 
are characterized by almost absolute specificity for aspartic acid in the P1 position. 
Caspases contain three main domains: a pro-domain, large (p20) and small (p10) 
catalytic subunits (Thornberry & Lazebnik, 1998) as shown in Figure 1.5. The pro-
domains of activator and inflammatory caspases contain protein–protein interaction 
domains (such as the caspase recruitment domain (CARD) and the death effector 
domain (DED) that link them to apoptosis signaling molecules (Degterev et al, 2003). 
The large domain contains the active site cysteine residue (Figure 1.5). All the 
caspases (ICE-like proteases) contain a conserved QACXG (where X is R, Q or G) 
pentapeptide active site motif. Activation of caspases involves the proteolytic 
cleavage of zymogens by auto-activation of pro-domain and activating other 
caspases to produce a heterodimer, two of which forms an enzymatically active 
heterotetramer (Figure 1.5). The activation of caspases can be initiated by the initiator 
caspases listed in Table 1.2, this inturn activate the downstream effector caspases. 
The autocatalytic cleavage of caspases is brought about by the close proximity by the 
adaptor proteins (Muzio et al, 1998). The CARD and DED domains interact with 
adaptor proteins to bring the caspases together for autocatalytic activity (Adams & 
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Cory, 2002). The caspase-8 gets activated by sequestering the adaptor protein Fas-
Associated Death Domain (FADD) into the Death Inducing Signaling complex (DISC) 
(Muzio et al, 1998). Caspase-9 gets activated by forming a heteromeric complex, 
termed ‘Apoptosome’ with the adaptor protein Apoptotic Protease Activating Factor 
(Apaf-1) (Ahmad et al, 1998). 
 
Subfamily Role Members 
I Apoptosis activator Caspase-2,-8,-9,-10 
II Apoptosis executioner Caspase-3,-6,-7 
III Inflammatory mediator Caspase-1,-4,-5,-11,-12,-13,-14
Table 1.2. Subfamily of Caspases and their function. Based on the homology of the aminoacids the 
caspases are differentiated into three subfamilies with specific functions 
. 
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Figure 1.5. The sketch of the three major groups of caspases. The executioner and activator caspases 
have the DED/CARD domain, while the three different classes of caspases have the p20 and p10 
domains. Scheme of pro-caspase activation. Cleavage of pro-caspase at the specific Asp-x- bonds 
leads to the formation of mature caspases, which comprises the heterotetramer (p20) 2-(p10) 2, and the 
release of the pro domains. 
1.2.4. Consequences of caspase activation 
During apoptosis, controlled demolition of the major structural components of 
the cell takes place. The activated executioner caspases, orchestrate the dismantling 
of the cell structures through cleavage of distinct critical cellular substrates, including 
poly (ADP-ribose) polymerase (PARP), lamins (Rao et al, 1996), fodrin (Martin et al, 
1995), gelsolin, filamin (Kothakota et al, 1997) and DNA PK which are involved in 
DNA repair, hence this ensues the DNA degradation (Wyllie, 1980). In healthy cells, 
the caspase activated DNases (CAD) is found in complex with an inhibitor in the form 
of ICAD (Liu et al, 1997). During apoptosis the ICAD become the substrate of 
activated caspases and gets degraded liberating the CAD to enter the nucleus and 
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complete its activity of DNA fragmentation (Enari et al, 1998; Sakahira et al, 1998). 
Several components of the focal adhesion sites are targets of caspases like, focal 
adhesion kinases, tensin and components to cell-to-cell adhesions like catenins, 
cadherins are targets of caspases (Brancolini et al, 1997; Steinhusen et al, 2001).   
When all kinds of caspase substrates are activated, the cell will go through a series of 
changes, including the activation of related genes, a decrease in DNA damage repair 
ability, and the activation of zymogens or inactivation of enzymes, cytoskeleton 
disassembly, and chromatin fragmentation (Taylor, Cullen et al. 2008). The cell 
inevitably undergoes apoptosis. 
1.2.5. Inhibitors of apoptosis (IAPs) the cellular inhibitor of caspases 
The IAP proteins, which were originally identified in the genome of 
Baculovirus on the basis of their ability to suppress apoptosis in infected host cells 
(Miller, 1999), have also been found in mammals and fruit flies (Salvesen & Duckett, 
2002a), but not in nematodes. There are eight mammalian IAPs, which include XIAP 
(X-linked IAP), c-IAP1, c-IAP2, ML-IAP (melanoma IAP)/Livin, ILP2 (IAP-like protein-
2), NAIP (neuronal apoptosis-inhibitory protein), Bruce/Apollon and survivin. The 
hallmark of IAPs is the Baculoviral IAP repeat (BIR) domain, a ~80-amino-acid zinc-
binding domain (Sun et al, 1999). The BIR domains fold as three-stranded ß- sheet 
surrounded by four α helices that form a hydrophobic core with a Zn ion at the center. 
The RING domain of IAPs can confer E3 ubiquitin ligase activity to the IAPs 
conferring to self regulation of the IAP by the degradation by proteasome (Lorick et al, 
1999). Other domains in IAPs include the caspase activation and recruitment domain 
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(CARD), phosphate loop and Ubiquitin Conjugating Domain (UBC) (Figure1.6). The 
three BIR domains are responsible for mediating protein- protein interaction. Although 
similar they have specificities for distinct intermediates. BIR2 and BIR3 have been 
shown to directly bind and inhibit the proteolytic activity of caspases (Eckelman & 
Salvesen, 2006). BIR2 selectively targets caspase-3 and caspase-7 while BIR3 is 
specific for caspase-9 and can permanently remove caspases through the 
ubiquitylation mediated proteasome pathway (Shi, 2002).  Interestingly caspase-9 
binds to several IAPs but selectively inhibited by XIAP, where as caspase-3 and -7 
are inhibited by XIAP, cIAP-1, cIAP-2 and NAIP (Salvesen & Duckett, 2002b). This 
difference occurs because of the difference in the mechanism of apoptosis inhibition. 
The cIAP-1 and -2 have a caspase-binding scaffold, while there is no caspase 
inhibitory activity (Eckelman & Salvesen, 2006). XIAP is hence the most potent 
among the IAPs, with its BIR2 domain specifically binding to the IAP binding motif of 
the active site of Caspases (Scott et al, 2005). As the RING domain have the E3 
ubiquitin ligase activity, in addition to degrading caspase-3 and -7 they also undergo 
auto-ubiquitination and cross-ubiquitinate in a RING dependent manner during 
apoptosis (Yang et al, 2000).  
The IAP mediated inhibition of caspases is antagonized by a family of protein 
that contain IAP binding tetra peptide motif, SMAC/DIABLO, released from the 
mitochondrial inter-membrane space. SMAC once released into the cytosol can 
promote the poly-ubiquitination of cIAP-1 and -2 leading to their degradation (Vaux & 
Silke, 2005a).  
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Figure 1.6. Molecular sketch of the cellular inhibitor of apoptosis protein. The cIAP-1/2 contains three 
baculoviral IAP repeat (BIR) domains with a CARD domain, while the CARD domain is absent in 
XIAP. A single BIR 3 domain makes the IAP, Survivin. 
Survivin, which contains a single BIR domain, does not inhibit caspase 
activity in vitro (Ambrosini et al, 1997). Another single BIR containing IAP, ML-
IAP/Livin, was reported to inhibit both caspase-3 and -9 although it does not seem to 
contain the sequence elements that are required for this inhibition. 
1.2.6. The Bcl2 family  
The first mammalian homolog for ced-3 was described in 1988 as Bcl-2, 
which is involved in B-cell lymphomas (Vaux et al, 1988). Bcl-2 transfected B cells 
were shown to be resistant towards apoptosis normally induced in B cells by IL-3 
withdrawal (Cleary et al, 1986; Tsujimoto et al, 1985): for the first time it was shown 
that the pathway toward tumorogenesis depends not only on the ability to escape 
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growth control but also depends on the ability to prevent apoptosis (Tsujimoto, 1989). 
The bcl-2 gene codes for a 25 kDa protein. The C terminal 21 amino acids encode a 
stretch of hydrophobic amino acids that are important in membrane docking: Bcl-2 
resides on the cytoplasmic face of the mitochondrial outer membrane, the nuclear 
envelop, and the endoplasmic reticulum. Deletion of the C terminus does not 
abrogate Bcl-2 survival function (Adams & Cory, 1998). Most Bcl-2 homolog has this 
hydrophobic C terminal domain, though they not necessarily are located on 
membranes but are cytosolic (e.g. Bax). While Bcl-2 and its most similar pro-survival 
homologs Bcl-xl and Bcl-w contain all four BH domains, the other pro-survival 
members contain at least BH1 and BH2 (Cory & Adams, 2002) (Figure 1.7). Eighteen 
mammalian B-cell lymphoma protein-2 (Bcl-2) family members were identified and 
they are subdivided into three sub-classes: anti-apoptotic or pro-survival (Bcl-2, Bcl-xl, 
Bcl-w, Mcl-1 and BFL-1/A1), multi-domain pro-apoptotic (Bax, Bok and Bak) and pro-
apoptotic BH3-only (Bad, Bid, Puma, Noxa, BIik, BLK, HRK, BNIP3 and Bim, Bmf). 
BH3-only proteins 
The pro-apoptotic BH3-only proteins are the most apical regulators of this 
death-signaling cascade, and are activated by multiple stimuli from inside or outside 
the cell to initiate the apoptotic response. They are regulated transcriptionally, and by 
post-translational modifications such as phosphorylation, ubiquitination, and 
proteolytic cleavage. Their BH3 domain is an amphipathic α-helix that serves as a 
binding motif for interaction with a hydrophobic groove on either multi-domain anti- or 
pro-apoptotic Bcl-2 family members (Adams & Cory, 1998). This BH3 domain-
mediated interaction of BH3-only proteins with multi-domain Bcl-2 family proteins 
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either antagonizes the survival activity of anti-apoptotic proteins or activates pro-
apoptotic Bax and Bak, the antagonism of survival pathway is cooperated by the 
activation of Bax and Bak (van Delft et al, 2006). The Bax and Bak are kept in check 
in healthy cells by the specificity of BH3-only proteins.  
 
 
Figure 1.7. Pro- and anti-apoptotic family members can heterodimerize: the BH1, BH2 and BH3 
domains of an anti-apoptotic member (e.g. Bcl-xl) form a hydrophobic cleft to which a BH3 amphipathic 
alpha helix can bind (Sattler et al, 1997). This BH3 cleft coupling, reminiscent of ligand-receptor 
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engagement, may account for all dimerization within the family. Heterodimerization is not required for 
pro-survival function but is essential for the pro-apoptotic activity in the BH3 subfamily.  
Bim is required for the removal of auto-reactive B and T cells thus play a role 
in autoimmunity (Bouillet et al, 2002). It is also induced by growth factor deprivation 
by class O forkhead box transcription factor-3A (FOXO3A) or by the transcription 
factors CEPB (CCAAT enhancer binding protein) or CHOP (CEBP homologues 
protein) in response to endoplasmic reticulum stress (Puthalakath et al, 2007). Bim 
and Bmf are associated with the microtubules and actin cytoskeleton respectively via 
interaction with Dynein light chains and their release can induce apoptosis 
(Puthalakath et al, 2001). It was recently reported that the BH3 peptides could induce 
mitochondrial fission and cell death in a Bax and Bak negative background (Shroff et 
al, 2009). Bim, a potent killer have high affinity to pro-survival proteins like Mcl-1 and 
Bcl-xlthereby liberating Bax, which is now unconstrained the default state for cell 
death (Fletcher & Huang, 2006). Bim, tBid and Puma are known to activate Bax and 
Bak directly while Bad and Noxa lower the threshold of activation by neutrilising pro-
survival Bcl-2 (Cartron et al, 2004; Kuwana et al, 2002; Letai et al, 2002). It is also 
shown that tBid can induce cell death by release of cytochrome c in an Bax and Bak 
dependent way, and not in cells lacking one of these (Wei et al, 2001; Zong et al, 
2001). This finding indicates that Bax and Bak lie downstream of BH3-only proteins. 
Bax and Bak 
The pro-apoptotic Bax remains in the cytoplasm in healthy cells, as its 
hydrophobic groove that serves as the receptor for the BH3-only proteins remain 
occluded by its C terminal trans-membrane domain. During death activation, activated 
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caspase-8 and tBid signal the conformational change of the protein, which leads to its 
oligomerisation and mitochondrial membrane localization, which leads to potential 
loss, and cell death (Annis et al, 2005; Antonsson et al, 2001). In contrast Bak is 
constitutively associated with the outer mitochondrial membrane where if form large 
oligomeric complexes in response to apoptotic stimulus (Nechushtan et al, 2001). The 
Bak in healthy cells are sequestered by Mcl-1 and Bcl-xl. While upon induction of 
apoptosis, Noxa dependent displacement of Bak from Mcl-1 followed by inactivation 
of Bcl-xl takes place (Willis et al, 2005). Once Bax and Bak oligomers are formed, the 
mitochondrial permeabilisation is favored, resulting in the release of pro-apoptotic 
factors into the cytoplasm (Kroemer et al, 2007). Before cytochrome c release Bax 
and Bak induce the mitochondrial fragmentation (Martinou & Youle, 2006). The BH1 
and BH2 domains of Bcl-2 family members (Bcl-2, Bcl-xland Bax) resemble 
membrane insertion domains of bacterial toxins: hypothetically they can form pores in 
organelles such as mitochondria, demonstrated in lipid bilayers in vitro. In yeast which 
lack Bcl-2 like proteins, CED-4 and caspases, Bax and Bak were shown to induce cell 
death, while Bcl-2 can protect, apparently by preventing mitochondrial disruption 
(Green & Reed, 1998). Bax and Bax-like proteins might mediate caspase-
independent death via channel-forming activity, which would promote the 
mitochondrial membrane potential lose. 
It is known that some of the BH3-only proteins like Bim and Puma, the ‘direct 
activators of Bax and Bak are more potent apoptosis inducers than the ‘derepressors’ 
Bad and Noxa (van Delft & Huang, 2006). Studies show that Bim and Puma have 
high affinity to all pro-survival members, than other members (Chen et al, 2005b). 
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This suggests that Bcl-2 pro-survival proteins must be neutralized to induce 
apoptosis. This was confirmed when (Chen et al, 2005b) co-expressed proteins like 
Noxa (which neutralizes Mcl-1), and Bad (which neutralizes Bcl-2, Bcl-xl and Bcl-w) 
induced apoptosis in cells. 
The anti-apoptotic Bcl-2 proteins 
The Bcl-2 pro-survival proteins act by directly interacting with Bax and Bak. 
Bak form complexes with Mcl-1 and Bcl-xl  by interacting with BH3 domain (Chen et al, 
2005a; Letai et al, 2002). In contrast, the BH3 of Noxa is highly specific for Mcl-1 and 
BFL-1/A1. The BH3 of Bid and Bim are also capable of binding the grooves of multi- 
domain Bak and promoting their oligomerization, whereas other BH3 protein likeBad 
appeared more exclusive for binding to multi-domain of anti-apoptotic proteins such 
as Bcl-2 and Bcl-xl (Cheng et al, 2001). A central checkpoint of apoptosis is the 
activation of caspase-9 by mitochondria. The BH4 domain of Bcl-2 and Bcl-xl can bind 
to the C terminal part of Apaf-1 (Sattler et al, 1997), thus inhibiting the association of 
caspase-9 with Apaf-1 (Hu et al, 1998; Huang et al, 1998; Pan et al, 1998). This 
process seems to be conserved from nematodes to vertebrates since in C. elegans 
CED-9 binds to CED-4, preventing it from binding and activating CED-3. This 
collective type of data leads to the notion of discrete roles for BH3-only protein 
interactions governed by the binding specificity of their BH3 for multi-domain grooves. 
The Myeloid Cell Leukemia sequence-1 (Mcl-1) was identified as an early-induced 
gene during myeloblast cell differentiation. Mcl-1 is one of the most important anti-
apoptotic proteins preventing inappropriate activation of Bax and Bak in healthy cells 
(Cuconati et al, 2003). Mcl-1 have C terminal trans-membrane domain that results in 
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its localization in the outer mitochondrial membrane (Yang et al, 1995), where it 
sequester Bak and maintain it in an inactive state. Recently, Sharma et al (2011) 
showed that the hypoxia-inducing factor (HIF-1α) can stabilize the Mcl-1, which 
increases its anti-apoptotic effect. 
1.2.7 NF-κB, the master regulator 
NF-кB (Nuclear Factor-KappaB) was initially discovered and characterized as 
a transcription factor required for B- cell specific gene expression, later it was found to 
be ubiquitously expressed and required for the inducible expression of many genes 
(Sen & Baltimore, 1986). NF-кB is a heterodimeric protein composed of different 
combinations of members of the Rel family of transcription factors,which are involved 
mainly in stress-induced, immune, and inflammatory responses (May & Ghosh, 
1998). In addition, these molecules play important roles during thedevelopment of 
certain hemopoietic cells (Franzoso et al, 1997), keratinocytes, and lymphoid 
organstructures (Baeuerle & Henkel, 1994; Mattson & Camandola, 2001). More 
recently, NF-кB family members have been implicated in neoplastic progression and 
the formation of neuronal synapses (Mattson and Camandola 2001). NF-кB is also an 
important regulator in cell fate decisions, such as PCD and proliferation control, and is 
critical in tumorogenesis (Baldwin, 1996b). NF-кB is composed of homo- and hetero-
dimers of five members of the Rel family including NF-кB 1(p50), NF-кB 2 (p52), RelA 
(p65), RelB, and c-Rel (Rel)(Sen & Baltimore, 1986). Hetero and Homo-dimerization 
of NF-кB proteins which exhibit differential binding specificities includes p50/RelA, 
p50/c-Rel, p52/c-Rel, p65/c-Rel, RelA/RelA, p50/p50, p52/p52, RelB/p50 and 
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RelB/p52 (May & Ghosh, 1998). All the Rel proteins contain a conserved N terminal 
region, called the RHD (Rel Homology Domain). The N terminal part of the RHD 
contains the DNA-binding domain, whereas the dimerization domain is located in the 
C-terminal region of the RHD. Close to the C terminal end of the RHD lays the NLS 
(Nuclear Localization Signal), which is essential for the transport of active NF-кB 
complexes into the nucleus (Baldwin, 1996a). NF-кB dimers are sequestered in the 
cytoplasm in un-stimulated cells via non-covalent interactions with a class of inhibitory 
proteins called I-кB (Baeuerle & Baltimore, 1988b). There are seven IкBs, namely IкB-
α, IкB-β, IкB-γ (NEMO), IкB-€, Bcl-3, p100, p105. The IкB have multiple copies of 30 
repeating aminoacids called ankyrin repeats, which binds with NF-кB and masks its 
NLS. Later (Baeuerle & Baltimore, 1988a) reported the inducible activation of NF-кB 
in response to signals like  Phorbol-12 myristate 13 acetate (PMA), which leads to the 
disruption of cytosolic I-кB. The phosphorylation and degradation via ubiquitination of 
IкB was later reported (Ghosh & Baltimore, 1990; Kerr et al, 1991) which releases the 
IкB bound NF-кB. IкB degradation is a tightly regulated process and can be inhibited 
by proteasome inhibitors (Brown et al, 1995; Chen et al, 1995). The high molecular 
weight kinases, IKK (IкB kinase), lead to the critical phosphorylation on Ser32 and 
Ser36 of IкB that initiates its degradation (DiDonato et al, 1997; Mercurio et al, 1997). 
The Rel/NF-кB proteins can be divided into two groups: Only RelA (p65), RelB and c-
Rel contain potent TDs (Trans-activation Domains) within sequences C terminal to 
the RHD (Ganchi et al, 1992). In contrast, p50 and p52 do not possess TDs, and 
therefore cannot act as transcriptional activators by themselves (Ganchi et al, 1992). 
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Figure 1.8. Mechanism of NF-кB activation. In an inactive stage the components of NF-кB is located in 
the cytosolic region complexed with the Inhibitor of kappa B (IkB). Upon activation with any 
extracellular signal, the Inhibitor of kappa B kinases (IKK) is activated and this in-turn phosphorylate 
the IkB, which results in its ubiquitination. The activated components of NF-кB then translocate to the 
nucleus and binds to specific DNA sequences called response elements. The DNA/NF-кB complex 
then recruits other proteins such as co-activators and RNA polymerasewhich results in downstream 
transcription of the target genes. 
NF-кB-1 and NF-кB-2 are produced as p105 and p100 precursors, 
respectively (Fan & Maniatis, 1991). The NF-кB-1 p105 precursor appears to undergo 
constitutive processing by the cellular proteasome that removes the C terminal IкB-
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like portion to generate p50. NF-кB-2 p100 precursor can be processed to remove the 
IкB-like C terminus, allowing the active p52 N terminal half to function in 
transcriptional regulation (Xiao et al, 2004a). Homo- or heterodimers of p50 and p52 
were even reported to repress kappaB site-dependent transcription, possibly by 
competing with other transcriptionally active dimers (e.g. p50/RelA) for DNA binding 
(Heissmeyer et al, 2001). 
NF-кB can be activated by exposure of cells to LPS (Lipopolysaccharides) 
(Janssens et al, 2002) or inflammatory cytokines such as TNF (Tumour Necrosis 
Factor) or IL-1 (Interleukin-1), growth factors, lymphokines, oxidant-free radicals, 
inhaled particles, viral infection or expression of certain viral or bacterial gene 
products, UV irradiation, B or T-Cell activation, and by other physiological and non 
physiological stimuli (Dixit & Mak, 2002). The most potent NF-кB activators are the 
proinflammatory cytokines IL-1 and TNF, which cause rapid phosphorylation of IkBs 
at two sites within their N terminal regulatory domain (Baldwin, 1996a). TNF, which is 
the best-studied activator, binds to its receptor and recruits a protein called TRADD 
(TNF-Associated Receptor Death Domain) (Ermolaeva et al, 2008; Wallach et al, 
1999a). TRADD binds to the TRAF2 (TNF Receptor-Associated Factor-2) that recruits 
NIK (NF-кB -Inducible Kinase) (Hsu et al, 1996; Sakurai et al, 2003). Both IKK1 and 
IKK2 have canonical sequences that can be phosphorylated by the MAP (Mitogen 
Activated Protein) kinase NIK/MEKK1 and both kinases can independently 
phosphorylate IkB-alpha or IkB-beta (Figure 1.8). TRAF2 also interacts with A20, a 
zinc finger protein whose expression is induced by agents that activate NF-кB. A20 
functions to block TRAF2-mediated NF-кB activation (Song et al, 1996). A20 also 
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inhibits TNF and IL-1 induced activation of NF-кB suggesting that it may act as a 
general inhibitor of NF-кB activation (Lee et al, 2000).  
1.2.8. The Akt/PKB signaling pathway 
Akt also known as protein kinase B is a serine threonine protein kinase 
(Bellacosa et al, 1991) that plays a critical role in glucose metabolism, cell 
proliferation, apoptosis and cell migration (Datta et al, 1999). Akt posses a protein 
domain called PH domain (plekstrine domain) which have high affinity to 
phosphoinositides (Franke et al, 1997). Akt is activated by upstream signaling events, 
as a consequence of the activated second messenger phopholipid kinase 
phophatidylinositol 3- kinase (PI3K) (Brazil & Hemmings, 2001; Nicholson & 
Anderson, 2002). Activated receptor tyrosine kinases activate PI3 kinases directly or 
through tyrosine phosphorylation of scaffolding adaptors like IRIS. The binding of PI3-
K generated phospholipids to the PH domain of Akt causes the translocation of Akt 
from cytoplasm to the plasma membrane (Downward, 1998). This brings Akt in close 
proximity to membrane bound protein kinase 3- phosphoinositide dependent protein 
kinase-1 and -2. PI3K phosphorylates PIP2 (phosphatidylinositol 3, 4 bisphosphate) to 
PIP3 (phosphatidylinositol 3, 4, 5 triphosphate) (Stokoe et al, 1997). These lipids 
serve as plasma membrane docking sites for proteins that harbor pleckstrin-homology 
(PH) domains, including Akt and its upstream activator PDK1 (Rong et al, 2001). 
Once bound to PIP3, Akt can be phosphorylated by its kinases at threonine 308 and 
serine 473 (Alessi et al, 1997; Sarbassov et al, 2005). Activated Akt can go on to 
activate or deactivate myriad of substrates. One of the most important functions 
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signaling downstream directly or indirectly is to regulate the cell survival (Zhou et al, 
2000). Akt enhances the survival of cells by blocking the function of pro-apoptotic 
proteins and processes. Akt negatively regulates the function or expression of several 
BH3-only proteins, which exert their pro-apoptotic effects by binding to and 
inactivating pro-survival Bcl-2 family members.  
 
Figure 1.9. Overview of the Akt activation and consequences after the binding of diverse array of 
growth factors and cytokines to the receptor. Binding of p85 subunit of PI3K activates the conversion of 
PIP2 to PIP3, which recruits the Akt from the cytosol to the plasma membrane where its conformation 
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change and phosphorylation by PDK1 takes place. This phosphorylates and wide ranges of protein 
substrates (like Bcl2, BAD, MDM2, GSK3, IKK-ß) thus regulating cell cycle and survival. 
For instance, Akt directly phosphorylates and inhibits the BH3-only protein 
Bad (Datta et al, 1997; Zha et al, 1996). Survival factors stimulate Akt mediated 
phosphorylation of Bad on S136, and this creates a binding site for 14-3-3 proteins, 
which triggers release of Bad from its target proteins (Datta et al, 2000). The ability to 
phosphorylate S136 on Bad is important for the survival effects of Akt on neurons and 
other cell types (Zhou et al, 2000). Akt also inhibits the expression of BH3-only 
proteins like Bim through effects on transcription factors, such as FOXO and p53 (Zhu 
et al, 2008). Akt phosphorylates FOXO1 on T24, S256, and S319, and it 
phosphorylates FOXO3a and FOXO4 on three equivalent sites (Lee et al, 2011). Akt 
phosphorylation of FOXO proteins occurs in the nucleus, and, as with Bad, 
phosphorylated T24 and S256 are bound by 14-3-3 proteins, which displace FOXO 
transcription factors from target genes and trigger their export from the nucleus 
(Brownawell et al, 2001). Through this mechanism, Akt blocks FOXO-mediated 
transcription of target genes that promote apoptosis, cell-cycle arrest, and metabolic 
processes. Akt also targets the phosphorylation and deactivation of another 
transcription factor MDM2 that transcriptionally regulates P53 (Mayo & Donner, 2001; 
Ogawara et al, 2002). BH3-only proteins Puma and Noxa are important transcriptional 
targets of P53. Another important regulation is the phosphorylation of GSK3 (Fang et 
al, 2000), which inhibits the pro-survival Bcl-2 family member Mcl-1 (Flusberg et al, 
2001). Under certain conditions Akt is also known to activate NF-кB pro-survival 
pathway also it blocks apoptosis induced by p38/JNK activation (Faissner et al, 
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2006). The Akt pathway with respect to apoptosis inhibition and cell survival is 
depicted in Figure 1.9. 
1.2.9. The extrinsic pathway of apoptosis 
The extrinsic pathway begins outside the cell through the activation of specific 
pro-apoptotic receptors on the cell surface. These extracellular death receptor ligands 
such as tumor necrosis factor (TNF) (Locksley et al, 2001; Schulze-Osthoff et al, 
1998), Fas ligand (FasL)/CD95L, and TNF-related apoptosis-inducing ligand 
(TRAIL)/Apo2L bind to their respective transmembrane receptors TNFR, Fas/CD95 
and DR4/DR5 respectively (Peter & Krammer, 2003; Strasser et al, 2000). Fas, one 
of the best-characterized death receptors, play crucial roles in a variety of 
immunological processes. This is reflected in the fact that mutations in the gene 
encoding Fas underlie most cases of autoimmune lymphoproliferative syndrome 
(ALPS), an autoimmune disease in children characterized by massive 
lymphadenopathy, peripheral accumulation of doubly negative T cells, and 
autoantibody production leading to hepatosplenomegaly, hemolytic anemia, and 
thrombocytopenia (Straus et al, 1999). In an extensively characterized FasL/FasR 
and TNF-α/TNFR systems, clustering of the receptors occur together with the binding 
of the homologues trimeric ligand (Chan et al, 2000). Consequently, cytoplasmic 
adapter protein gets recruited to the receptor/ligand through the death domain. The 
binding of TNF-α to the TNFR, with a simultaneous block in protein synthesis, results 
in the binding of TRADD (TNFR associated death domain) with FADD (Fas 
associated death domain) and RIP (Hsu et al, 1995). Binding of TNF-α to the TNFR 
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can lead to activation of NF-кB when protein synthesis is not blocked (Legler et al, 
2003). Receptor aggregation in response to the pro-apoptotic Fas ligand binding and 
TNF initiates the formation of specific intracellular death-induced signaling complexes 
(DISCs) (Micheau & Tschopp, 2003; Peter & Krammer, 2003), where the adaptor 
molecule Fas-associated death domain (FADD) serves as platform for recruitment 
and bringing the pro-caspases to close proximity facilitating autocatalytic activity and 
activation of caspases-8 and -10 (Figure 1.10). The activation of caspase-8 in turn 
cleave downstream caspases, such as caspase-3 and caspase-7, to execute cell 
death; alternatively, caspase-8 can cleave the BH3-only pro-apoptotic protein Bid, 
which in turn amplifies the cell death signal by causing mitochondrial damage and cell 
death (Peter & Krammer, 2003). DISC formation is also modulated by several 
inhibitory mechanisms, including c-FLICE inhibitory protein (c-FLIP), which exerts its 
effects on the DISC by interacting with FADD to block initiator caspase activation; and 
decoy receptors, which can block ligand binding or directly abrogate pro-apoptotic 
receptor stimulation (Ashkenazi, 2008; French & Tschopp, 1999).  
It has been shown that activation of the extrinsic pathway through the binding 
of CD95L/FasL to CD95/Fas can result in 2 apoptotic programs, termed type I and 
type II. Type I cells are able to overcome the need for mitochondrial amplification of 
the death signal in CD95-mediated apoptosis by producing sufficient amounts of 
caspase-8 at the DISC to directly cleave and activate effector caspases and execute 
cell death (Scaffidi et al, 1998). Because type I cells bypass mitochondrial 
involvement in CD95-mediated apoptosis, expression of Bcl-2 or Bcl-xl has no 
inhibitory effect on their apoptotic program. Conversely, type II cells produce minimal 
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amounts of active caspase-8 at the DISC and require the mitochondrial amplification 
of the CD95 signal (Scaffidi et al, 1998). The signaling to mitochondria is probably 
through the pro-apoptotic BH3 domain of the Bcl-2 family member, Bid. The cleavage 
of Bid by caspase-8 (Li et al, 1998) results in its translocation to the mitochondria 
where it initiates the release of mitochondrial factors, which in turn augment cell 
death. Because type II cells rely on the apoptotic function of mitochondria, expression 
of Bcl-2/Bcl-xl does confer protection from CD95-mediated apoptosis. 
An explanation for the differences between type I and type II cells remains 
unclear, although differential expression of inhibitors of the death receptor signaling 
cascade, such as c-FLIP or XIAP, has been suggested to play a role (Walter et al, 
2008). 
1.2.10. The intrinsic pathway of apoptosis 
As the name suggests the intrinsic pathway is triggered by severe cell stress 
like DNA damage, a defective cell cycle and detachment from the extracellular 
matrix, hypoxia and loss of cell survival factors.The intrinsic apoptotic pathway hinges 
on the balance of activity between pro- and anti-apoptotic members of the Bcl-2 
super family of proteins, which act to regulate the permeability of the mitochondrial 
membrane (Coultas & Strasser, 2003). Members of the Bcl-2 family contain signature 
domains of homology called Bcl-2 homology (BH) domains as described above. Each 
of the BH3-only protein acts as sensor to the cellular stress (Bouillet & Strasser, 
2002). 
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Figure 1.10. The intrinsic and extrinsic pathway of apoptosis. The extrinsic pathway is initiated by the 
death receptor ligation, which induces recruitment of FADD and pro-caspase-8 to death inducing 
signaling complex. Auto activation of caspase-8 can directly activate caspase-3 in type I cells. In type II 
cells amplification of the death signal via mitochondria is required which is mediate by Bid. Bax and 
Bak activation leads to mitochondrial membrane potential loss and apoptogenic factors are released 
into the cytosol. In the intrinsic pathway death inducing stimuli like DNA damaging agents leads to 
activation of BH3-only proteins accompanied by the down regulation of Bcl-2 like proteins. 
BH3-only proteins activate the multi-BH domain pro-apoptotic proteins Bax 
and/or Bak, which then allow for permeabilization of the mitochondrial membrane. 
The anti-apoptotic Bcl-2 proteins Bcl-2 and Bcl-xl act to prevent permeabilization of 
the outer mitochondrial membrane by inhibiting the action of the pro-apoptotic Bcl-2 
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proteins Bax and/or Bak (Figure 1.10). Upon membrane permeabilization, cytochrome 
c and the pro-apoptotic protein SMAC/DIABLO are then able to translocate from the 
intermembrane space of the mitochondria into the cytosol. As part of the intrinsic 
apoptotic pathway, the SMAC/DIABLO protein released from the mitochondria 
promotes apoptosis by directly interacting with IAPs and disrupting their ability to 
inactivate the caspase enzymes (Srinivasula et al, 2000). Hence, the intrinsic 
pathway is sometimes referred to as the mitochondrial pathway. Upon release from 
the mitochondria, cytochrome c forms a complex in the cytoplasm with adenosine 
triphosphate (ATP), an energy molecule, and the adaptor Apaf-1, forming a large 
multiprotein structure known as the apoptosome. Assembly of the apoptosome is 
highly regulated and may be driven by nucleotide exchange factors and/or ATPase-
activating proteins. The primary function of the apoptosome seems to be 
multimerization and allosteric regulation of the catalytic activity of caspase-9. Initiator 
caspase-9 is recruited into the apoptosome and activated from within the adaptor 
protein complex, which in turn activates the downstream effector caspases-3, -6, 
and/or -7 (Thornberry & Lazebnik, 1998). Besides the release of cytochrome c from 
the intra-membrane space, the intra-membrane content released also contains 
apoptosis inducing factor (AIF) to facilitate DNA fragmentation and chromatin 
condensation. It is involved in initiating caspase independent pathway of apoptosis. 
1.2.11. Perforin/granzyme pathway 
In the granzyme B pathway, Perforin and granzyme B are released by 
cytotoxic T lymphocytes when they recognize antigen bearing cells (Zhao et al, 2006). 
Granzyme B is exophytically released through the plasma membrane with the aid of 
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the trans-membrane pore forming protein perforin (Shi et al, 1997). Once inside the 
cell it can directly activate caspase-3 or specifically cleave Bid and initiate the intrinsic 
pathway of cell death (Goping et al, 2003). Granzyme B can cleave proteins at 
aspartate residues and thus activate pro-caspase-10 and can cleave factors like 
ICAD (Sakahira et al, 1998). 
1.3. Manipulation of host cell death pathway during microbial infections  
Other than maintaining the homeostasis of the immune system, host cell 
death is a major factor determining clinical progression and disease severity in host 
pathogen interactions. The clearance of infected host cells is necessary to inhibit 
microbial replication and dissemination. Several forms of host cell death have been 
described during infection, as part of the host defense system or as a component of 
the survival strategy of the pathogen. The type of death the cell undergoes depends 
on the nature of the pathogen, pathogen load and site of infection. It is thus not 
surprising that pathogens have evolved an array of toxins and virulence factors to 
modulate host cell death pathways. Apoptosis, necrosis, and pyroptosis constitute the 
three major cell death modes for elimination of infected cells. The cellular factors that 
comprise the cells death machinery and are prone to manipulation by pathogens are 
summarized in Figure 1.11, reviewed in (Bohme & Rudel, 2009; Lamkanfi & Dixit, 
2010).  
1.3.1. Regulation of apoptosis during infection 
Cells induce intrinsic apoptosis pathway to restrict the growth and 
reproduction of many pathogens. Recently it was shown that induction of intrinsic 
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pathway limited the facultative intracellular pathogen Legionella pneumophila 
(Nogueira et al, 2009). Defective or delayed apoptosis can lead to amplified 
pathogenesis and tissue damage (Marriott et al, 2005). The extrinsic apoptosis 
pathway equally contributes to the resistance against pathogenesis, as deletion of 
FasL prevented apoptosis followed by Pseudomonas aeruginosa infection and this 
lead to hyper susceptibility to sepsis-associated lethality (Grassme et al, 2000; Jones 
et al, 2002). The induction of apoptosis is however not always protective to the host 
as the pathogens can hijack the apoptotic machinery to eliminate the immune 
response. Many pathogens like Staphylococcus aureus and Listeria monocytogenes 
produce toxins and other virulence factors that activate the host apoptotic machinery 
(Weinrauch & Zychlinsky, 1999), while other pathogens like Yersinia enterocolitica 
and Salmonella typhimurium interfere with the NF-кB  and MAP kinase signaling 
cascades and induces cell death (Collier-Hyams et al, 2002; Monack et al, 1996). A 
well known example of such significant disease pathogenesis and tissue damage is 
the rapid depletion of lmyphocytes in patients infected with HIV (Badley et al, 2000). 
Obligate and facultative intracellular pathogens also benefit for preventing apoptosis 
to facilitate survival and replication. For instance the obligate intracellular pathogen 
like Rickettsia rickettsii stimulates NF-кB signaling in infected vascular endothelial 
cells in order to prevent host cell death and to continue replicating unabated (Clifton 
et al, 1998). Coxiella burnetii, protects infected cells from apoptosis during the early 
invasive stages of infection, presumably by blocking cytochrome c release from 
mitochondria (Luhrmann & Roy, 2007). Infection with Neisseria gonorrhoeae leads to 
the down-modulation of pro-apoptotic proteins Bim and Bad which accounts for 
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inhibition of host PCD. Another successful strategy to promote host cell 
survival is the phosphorylationof  the  extracellular signal  regulated  kinase  Erk 
and Akt  induced  by  a  multitude  of  bacteria,  including  Neisseria gonorrhoeae 
(Howie et al, 2008), Coxiella burnettii (Voth and Heinzen 2009),  and 
Salmonella  enterica  serovar  Typhimurium (Knodler et al, 2005a).  Thus, the 
induction or inhibition of host cell apoptosis is dependent on a delicate balance of pro- 
and anti-apoptotic strategies during host-pathogen interactions (Figure1.11). 
1.3.2. Regulation of necrosis during infection 
Reports demonstrating the induction or inhibition of programmed necrosis are 
very limited. A vaccinia virus strain expressing the CrmA homolog B13R/Spi2 was 
recently demonstrated to induce necrosis in adipocytes and hepatocytes in wild-type 
mice, while necrosis was markedly attenuated in RIP3 knockout mouse (Cho et al, 
2009). It was also reported that in murine cytomegalovirus infection RIP3 induced 
necrosis is suppressed by the viral inhibitor of RIP activation (Upton et al, 2010). The 
tools for characterizing and interfering with necrotic cell death are currently being 
developed like the recently generated RIP1-specific small molecule inhibitors 
(Degterev et al, 2008). Necrotic cell death was also shown in murine myoblast cells 
exposed to alpha toxin of the bacterial pathogen Clostridium septicum, the causative 
agent of clostridial myonecrosis (Kennedy et al., 2009). The reports investigating the 
in vivo consequences of inducing necrosis suggest that it may contribute to the 
capability of host to limit and clear the infection by removing intracellular replication 
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niches and by enhancing the host’s defensive responses through the release of pro-
inflammatory cytokines and endogenous danger signals. 
1.3.3. Regulation of pyroptosis during infection 
Shigella flexneri, the etiological agent of bacillary dysentery, was the first 
pathogen reported toinduce pyroptosis in infected macrophages (Hilbi et al, 1998). 
Subsequent studies demonstrated pyroptotic death of macrophages and dendritic 
cells infected with Salmonella typhimurium, Pseudomonas aeruginosa, and 
Legionella pneumophilab (Monack et al, 2001; van der Velden et al, 2003). All these 
pathogens induce caspase-1 activation through the Ipaf inflammasome. With the 
notable exception of Shigella, this happens following delivery of bacterial flagellin into 
the macrophage cytosol. Because Shigella lacks flagellin, it remains to be determined 
how this pathogen induces activation of the Ipaf inflammasome. As with necrosis, the 
destruction of intracellular replication niches and the release of inflammatory 
cytokines and endogenous alarmins such as HMGB1 may represent key mechanisms 
by which pyroptosis may contribute to the anti-infectious responses of the host. 
1.3.4. Apoptosis and host cell modulation by Chlamydiales 
Obligate intracellular bacteria, Chlamydia confer resistance to the host cell 
against a variety of apoptotic stimuli, including the action of cytotoxic T cells (Fan et 
al, 1998b). The bacteria are thus able to maintain a long-term relationship inside the 
host cell and complete their replication cycle inside the cell, at the end of which 
numerous elementary bodies are produced and released to infect other cells. 
Chlamydia can sometimes develop long-term chronic infections that could contribute 
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to diseases such as atherosclerosis. Protection of the host cell against apoptosis 
would acquire greater significance for the bacteria under such conditions. It is not 
surprising, therefore, that persistently infected cells have also been shown to be 
potently resistant to various forms of apoptosis (Dean & Powers, 2001). Apoptosis 
resistance has been attributed to all major chlamydial species viz. Chlamydophila 
pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, Chlamydophila caviae, 
as well as Chlamydia muridarum (Coutinho-Silva et al, 2001; Fan et al, 1998b; 
Rajalingam et al, 2001a; Zhong et al, 2006). Of these, C. trachomatis and C. 
pneumoniae have been widely studied for their strong anti-apoptotic effect and 
relevance to human diseases, reviewed under Sharma and Rudel (2009). The 
chlamydial infection protects cells against different forms of apoptosis described 
above (extrinsic, intrinsic and granzyme B), mediated by various stimuli including 
staurosporine (STS), TNF-α, etoposide, granzyme B/perforin, and UV light (Fan et al, 
1998b; Fischer et al, 2001; Rajalingam et al, 2001a) (Figure1.11). Chlamydia has 
evolved several strategies to escape host immune response. Chlamydia can down 
regulate the expression of MHC class I and II molecules, thus avoid the recognition of 
host cells by CD+ T cells (Zhong et al, 1999; Zhong et al, 2000), they also release 
some soluble factors that prime the by-stander uninfected cells for less MHC class I 
expression which would promote more rapid immune evasion upon pathogen entry 
and help promote unfettered spread of infections (Ibana et al, 2011). Analysis of 
apoptosis pathway in Chlamydia infected cells showed that they resist the 
cytochrome c release from the mitochondria to the cytosol, caspase-9 activation and 
processing of caspase-3 was prevented as expected (Fan et al, 1998b). Later it was 
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also found that the infected cells fail to achieve activation of Bax and Bak, the 
regulators of mitochondria permeabilisation (Xiao et al, 2004b). Chlamydia infection 
leads to the Chlamydia protease like activity factor (CPAF) dependent broad scale 
degradation of BH3-only proteins (Dong et al, 2005; Paschen et al, 2008), but later 
Rajalingam et al (2008a) reported that there was no noticeable degradation of these 
pro-apoptotic proteins. It was recently reported that persistant chlamydial infection 
does not depend on CPAF for resistance to apoptosis (Rodel et al, 2012). Chlamydia 
infected cells resist host apoptotic machinery at different levels, not only at 
mitochondria level but also downstream of it (Fischer et al, 2001). Chlamydia also 
interferes with the host protein synthesis, upregulation and stabilization of certain anti-
apoptotic proteins like cIAP-1, cIAP-2, XIAP and Mcl-1 (Paland et al, 2006b; 
Rajalingam et al, 2008a; Rajalingam et al, 2006a). Moreover, the significance of the 
anti-apoptotic proteins in conferring apoptosis resistance became clear from the RNAi 
technology reported in Rajalingam et al (2006a). RNAi screen to identify the critical 
host factors revealed Bcl-2 and Mcl-1 as the targets. Later it was observed that 
activation of Raf/MEK/ERK pathway is required for the stabilization of Mcl-1 
(Rajalingam et al, 2008a). One another host factor that was activated and stabilized 
Mcl-1 was the transcription factor HIF-1α (Sharma et al, 2011). 
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Figure 1.11. Modulation of cell death signaling cascades by bacterial pathogens. (Modified from (Bohme & 
Rudel, 2009)). Apoptosis is activated by intrinsic /extrinsic pathway. Bacterial pathogens (indicated in red) 
interfere at several points with either the regulators or executioners of the pathway. 
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1.4. Aim of the work 
The present study aims at investigating the evolutionary conservation of 
infection induced cell death inhibition among Chlamydiales. The apoptotic response 
of human cells infected with the Chlamydia-like organism Simkania negevensis (Sn) 
was under study. Sn maintains a long-term relationship with the host cells, as they 
can infect and remain upto 14 days in cell cultures. This bacterium ensures to keep 
the cell healthy and alive until it completes its life cycle. This aroused the curiosity as 
how this pathogen regulates the host signaling and remains hidden from the host 
immune response. Hence, this study was aimed to find if and how Sn infection 
regulates the signaling pathways in host cells. The different cell death pathways upon 
induction with various cell death inducers in Sn-infected cells were aimed for 
investigation. It was interesting to explore how similar was the pathways subverted in 
Sn-infected cells compared to Chlamydia, as they belong to the same family. This 
work supports the hypothesis of evolutionary conserved signaling pathways to 
apoptosis resistance as common denominators in the order Chlamydiales. 
 
 
 
 
 
 
 
   68
2. Materials and methods 
2.1. Materials 
2.1.1. Cell lines used in the study 
Cell lines Features Origin Source/Donor 
HeLa 229 Cervical adenocarcinoma Human ATCC CCL-2.1 
HEp-2 cells Laryngeal carcinoma Human ATCC CCL-23 
HT1080 Wild 
type 
Connective tissue 
(fibrosarcoma) 
Human ATCC CCL-121 
HT1080 (IкB 
mutant) 
Connective tissue 
(fibrosarcoma) with IкB under 
super repressor 
Human ATCC CCL-121 
Table 2.1. Human tissue culture cell lines used in the study 
2.1.2. Bacterial strain used in the study 
Bacteria Strain Source/Donor 
Simkania negevensis Z ATCC VR-1471TM 
Table 2.2. Bacterial strain used in the study 
 
2.1.3. Amoebal strain used in the study  
 
Amoeba Strain Source/Donor 
Acanthamoeba castellanii C3 ATCC 50739 TM 
Table 2.3.  Amoebal strain used in the study 
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2.1.4. Cell culture medium and buffers 
Medium Ingredients 
Cell culture media (HeLa 229 cells) 
 
1x RPMI 1640 + L-Glutamax + 25 mM 
HEPES (GIBCO,Germany),10 % (v/v) heat 
inactivated FCS (Biochrom) 
 HT 1080 WT and IкB mutants 1x RPMI 1640+ L-Glutamax + 25 mM HEPES 
(GIBCO, Germany),10 % (v/v) heat 
inactivated FCS (Biochrom) 
Simkania culture media 1x RPMI 1640+ L-Glutamax + 25 mM HEPES 
(GIBCO, Germany), 10 % (v/v) heat 
inactivated FCS (Biochrom), Penicillin (100 
U/ml), Streptomycin (100 µg/ml), Vancomycin 
(50µg/ml), Gentamycin (8 µg/ml), 
Cycloheximide (1 µg/ml) 
Freezing media 1x RPMI 1640 + L-Glutamax + 25 mM 
HEPES (GIBCO, Germany), 10 % (v/v) heat 
inactivated FCS(Biochrom), 10 % (v/v) DMSO
Transfection media Cell culture medium + 20% (v/v) Optimem 
(GIBCO) 
SPG buffer  0.22 M sucrose, 10 mM Na2HPO4, 3.8 
KH2PO4, 5 mM Glutamate 
PEI stock solution Dissolve PEI powder to a concentration of 2 
mg/ml in water which has been heated to 
80°C. Allow solution to cool to room 
temperature.Adjust pH to 7.0 with 5 M HCl. 
Filter sterilize. Freeze aliquots at -80°C. 
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Amoebal culture medium 
(Peptone yeast extract glucose (PYG)) 
Peptone (20g), glucose (18g), yeast 
extract (2g), sodium citrate (1g), MgSO4 
7H2O (980mg), Na2HPO4 7H2O (355mg), 
KH2PO4 (340mg) per liter of medium. 
pH-6,7. 
Encystment medium 95 mM NaCl, 5 mM KCl, 8 mM MgSO4, 
0.4 mM CaCl2, 1 mM NaHCO3, 20 mM Tris–
HCl, pH 9.0. 
Table 2.3. List of medium and buffers used for cell cultures. 
2.1.5. Buffer and Solutions 
Buffers and solutions were prepared using Millipore Q-distilled water. 
Chemicals were purchased from Sigma (Deisenhofen, Germany) or Roth (Karlsruhe, 
Germany), unless indicated otherwise. 
2.1.5. i. Buffer for Immuno fluorescence 
Buffer Ingredients 
PBS (1x) (/L) 
 
8 g NaCl, 0.2 g KCl, 2.68 g Na2HPO4 (1xH2O), 0.24 g 
KH2PO4,adjust to pH 7.4 
Fixing buffer (/L) 1x PBS + 4% (w/v) PFA, adjust to pH 7.2 
Permeabilization buffer 1x PBS + 0.2% (v/v) TritonX 100 
Blocking buffer 1x PBS + 10% (v/v) FCS 
Mowiol mounting medium 
 
2.4 g Mowiol 488, 6 g glycerol, 6 ml H2O, 12 ml 0.2 M 
Tris/HCl, adjust to pH 8.5 
Table 2.4. Buffers and components used for immunofluorescence. 
2.1.5.ii. Buffer for Immunoblotting 
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Buffer Ingredients 
10 x SDS buffer (/L) 30.275 g Tris, 144 g glycine, 10 g SDS 
10x Semi dry buffer (/L) 24 g Tris, 113 g glycine, 2 g SDS 
1x Semi dry transfer buffer 1x semi dry buffer + 20% (v/v) methanol 
10x TBS (/L) 60.5 g Tris, 87.6 g NaCl, adjust to pH 7.5 with HCl 
 TBST20 1 x TBS + 0.5% (v/v) Tween20 
Blocking solution TBST20 + 5% (w/v) dry milk powder or BSA 
Stripping buffer (500 ml) 
 
7.5 g glycine, 0.5 g SDS, 1.54 g DTT, 5 ml Tween20, 
Adjust to pH 2.2 
 2x Laemmli buffer 
 
100 mM Tris/HCl  [pH 6.8], 20% (v/v) glycerol, 4% 
(w/v) SDS, 1.5% (v/v) 2‐mercaptoethanol, 
bromophenol blue 
Lysis buffer for phospho protein 20 mM HEPES, 400 mM NaCl, 10 mM KCl, 20% 
(v/v) glycerol, 0.5% (v/v) Nonidet P-40, 1x 
Complete, 1x PhosSTOP 
12% SDS lower gel solution 
 
 
For 10 ml: 3.3 ml H2O, 4 ml 30% (v/v) 
acrylamide:bisacrylamide mix (37.5:1), 0.1 ml 10% 
(w/v) SDS, 2.5 ml, 1.5 M Tris/HCl [pH 8.8], 0.1 ml 
10% APS, 4 μl TEMED 
SDS upper gel solution 
 
 
For 5 ml: 3.4 ml H2O, 0.83 ml 30% (v/v) acrylamide: 
bisacrylamide mix (37.5:1), 0.63 ml 1.0 M Tris/HCl 
[pH 6.8], 0.1 ml 10% (w/v) SDS, 0.05 ml 10% APS, 
5 μl TEMED  
Table 2.5. Buffers and components used for immunostaining. 
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2.1.6. Commercial Kits used in the study 
Name Purpose Company/Donor 
a.Caspases Glo-8 assay Caspases-8 activation Promega 
b. DeadEndTM Fluorometric 
TUNEL Kit 
Measure apoptosis Promega 
Table 2.6. List of commercial kits used in the study. 
2.1.7. Inhibitors, Inducers used in the study 
Name Purpose Company / Donor 
a. TNF-α Apoptosis inducer BD Pharmingen 
b. LY 294002 PI3 kinase inhibitor Cell Signaling 
c. CAPE NF-кB inhibitor Sigma 
d. IKK-2 inhibitor IV NF-кB inhibitor Calbiochem 
Table 2.7. List of inducers and inhibitors used in the study. 
2.1.8. Fine chemicals 
Compound Manufacturer 
a. BMH Sigma 
b. Complete protease inhibitor Roche 
c. DRAQ5 Alexis 
d. ECL immunoblotting substrate Thermo 
e. Hoechst 33342 Sigma 
f. Syto 82 Invitrogen 
g. Phalloidin Invitrogen 
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h. LipofectamineTM 2000 Invitrogen 
i. PhoSTOP (phosphatase inhibitor) Roche 
Table 2.8. List of fine chemicals used in the study. 
2.1.9. Antibodies  
Name Source Company Product # Dilution Application
Akt rb Abcam 93856 1:1000 IB 
ß-Actin ms Sigma A5441 1:3000 IB 
Bad rb Cell signaling 9292 1:1000 IB 
Bax rb Abcam 16910-50 1:1000 IB/IF 
Bak rb Santa Cruz 526 1:1000 IB 
Bcl-2 ms Santa Cruz 509 1:1000 IB 
Bid rb Santa Cruz 11423 1:1000 IB 
Bim rb Santa Cruz 2819 1:1000 IB 
Bmf rb Cell signaling 4692 1:1000 IB 
Caspase-3 rb Cell Signaling 9665 1:1000 IB 
Cl caspase-3 rb Cell Signaling 9661 1:200 IF 
Caspase-9 rb Cell signaling 9502 1:1000 IB 
cIAP-1 rb Abcam 2399 1:1000 IB 
cIAP-2 rb Abcam 23423 1:1000 IB 
Chla Hsp 60 ms ThermoScientific MA3-023 1:3000 IB/IF 
Cytochrome C rb Santa Cruz 7159 1:1000 IB/IF 
Erk rb Cell Signaling 9108 1:1000 IB 
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IкB-α rb Cell Signaling 9242 1:1000 IB 
Mcl-1 ms Abcam 31948 1:1000 IB 
Mek rb Santa Cruz 252 1:1000 IB 
NF-кB rb Santa Cruz 372 1:1000 IB/IF 
PARP rb Santa Cruz 7150 1:1000 IB 
p Akt rb Cell Signaling 4060 1:1000 IB 
p Erk ms Cell Signaling 9106 1:1000 IB 
p Mek rb Cell Signaling 2354 1:1000 IB 
Puma rb Cell Signaling 4976 1:1000 IB 
Sn rb   1:50 IF 
Tom40 rb Santa Cruz  11414   1:500 IB 
Table 2.9. List ofPrimary antibodies used for Immunoblotting (IB), Immunofluorescence(IF). 
Secondary antibody Source Company Dilution Application 
ECL anti-mouse IgG 
HRP linked 
Goat/Donkey GE healthcare 1:2500 IB 
ECL anti-rabbit IgG 
HRP linked 
Sheep /Donkey GE healthcare 1:2500 IB 
Anti mouse Cy2 
linked 
Goat Dianova 1:200 IF 
Anti rabbit Cy2 linked Donkey Dianova 1:200 IF 
Table 2.10. Secondary Antibody used in the study. 
2.1.10. Technical equipment 
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The following technical devices were used in this study 
Hera Cell 150 incubator (Thermo), Hera Cell sterile bench (Thermo), Rotanta 
460R centrifuge (Hettich), AvantiTM J-25I centrifuge (Beckman Coulter), cold 
centrifuge 5417R (Eppendorf), Owl Hep semidry electro-blotting system (Thermo), 
PerfectBlueTM Dual Gel Twin PAGE chambers (Peqlab Biotechnology), DM1500 
confocal microscope (Leica), confocal Leica TCS SP5, DMR epifluorescence 
microscope (Leica), DMIL light microscope (Leica), plate reader infinite M 200 
(TECAN), Thermo-mixer comfort (Eppendorf), 2100 Bioanalyzer (Agilent 
Technologies), G –storm GS1 thermo cycler (GR1), Step One Plus RT PCR System 
(Applied Biosystems), Nano drop 1000 spectrophotometer (Peqlab Biotechnlogy), 
ultra low temperature freezer (New Brunswick scientific), liquid Nitrogen tank (CBS 
2300 series). 
2.1.11. Software used 
Windows XP, Microsoft Office 2007, EndNote X5, Adobe Photoshop CS4, 
Corel Draw X4, LAS-AF confocal microscopy software, ImageJ. 
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2.2. Methods 
2.2.1. Cell culture 
All cells were cultured in 75 cm2 cell culture flasks (Greiner) in the 
corresponding medium as described above (see Table 2.3). The cells were 
maintained in a humidified incubator (Thermo) at 37 °C with 5 % CO2. The cells were 
in culture only until ten passages. Trypsin-EDTA was used for splitting the cells upon 
confluence. The adherent epithelial cells were washed with sterile PBS (GIBCO, 
Invitrogen) once and detached by incubation with 1 ml Trypsin/EDTA (GIBCO, 
Invitrogen) per flask. Trypsinization was stopped after 3-5 minutes by re-suspending 
the cells in FCS containing medium. 10-20 % of cells were transferred into a fresh 
cellculture plate further cultured in fresh medium. 
2.2.1a. Amoebal culture 
Acanthamoeba castellanii, originally isolated as a cell culture contaminant 
was obtained from American Type Culture Collection (Mannasas, VA, USA). The 
amoebae were cultured axenically in peptone yeast glucose (PYG) medium at 25oC. 
Encystment was induced by washing the cells with phosphate buffer saline and 
incubating in encystment medium for 16h. 
2.2.2. Cryo stocking of cell lines  
For long term storage, and as the cells were maintained for no more than ten 
passages the same trypsinization procedure was performed to detach cells from cell 
culture plates, transferred to a 15 ml tube (Greiner) with 5 ml RPMI1640 + 10% FBS. 
After centrifugation at 800 rpm (Hettich) for 5 min, the cell pellet was resolved in 3 ml 
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stocking medium with 10% DMSO (cryoprotectant) and aliquoted into 1 ml per cryo 
tube, gradually cooled to -80°C in isopropanol after which the cryo tubes were 
transferred to liquid nitrogen tank where the temperature is -186°C. For thawing of 
cell stocks, frozen cells were rapidly thawed at 37 °C and immediately transferred into 
pre-warmedmedium for re-culture. Cells are usually seeded in plates one night before 
performing experiments. 
2.2.3. Infection with Simkania negevensis 
The infection procedure was similar to as described above, but the media was 
1x RPMI 1640+ L-Glutamax +25mM HEPES (GIBCO, Germany) with 10 % (v/v) heat 
inactivated FCS (Biochrom) and penicillin (100 U/ml), streptomycin (100 µg/ml), 
vancomycin (50 µg/ml), gentamycin (8 µg/ml) (to prevent any contamination). The 
media also contained cycloheximide (1 µg/ml); an effective inhibitor of protein 
biosynthesis in eukaryotes, at a lower concentration restricts the cell division. Since, 
Sn needs nearly 5 days to complete the life cycle at a MOI 1 the use of cycloheximide 
was inevitable. 
2.2.4. Preparation of bacterialstocks 
Owing to the obligate intracellular life style, Chlamydiales cannot be cultivated 
invitro on solid or in liquid media. Therefore, infectious EB had to be prepared from 
infected cell cultures and stored as frozen stocks for later usage. In order to prepare a 
stock of Simkania negevensis Z, HeLa 229 or Hep-2 cells were seeded in a 75 cm2 
cell culture flask, infected at MOI 1, and incubated at 35°C and 5% CO2 for 72 h, 
respectively. Infected cells were detached with a rubber policeman (Sarstedt) and 
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transferred to a falcon tube with sterile glass beads. Cells were ruptured by vortexing 
for 3 min and the supernatant containing chlamydial EB was transferred to twelve 150 
cm2 culture flasks of HeLa 229 or Hep-2 cells for propagation of infection in a dilution 
of 1:100. After 72 h of incubation, the cells were lysed as above. To remove cell 
debris, the suspension was centrifuged at 2,000 rpm for 10 min at 4°C (Hettich) 
followed by a centrifugation step at 25,000 x g for 1 h at 4°C (Beckman Coulter). The 
bacterial pellet was washed once with SPG (sucrose phosphate glucose) buffer, 
centrifuged as above, and resolved in 5 ml SPG buffer (Table 2.3). In order to 
separate clumps of bacterial EB, the bacterial suspension was passed through a 20 
then 18 gauge needle for several times. The suspension was aliquoted and stored at 
-80°C. For each infection experiment, aliquots were freshly thawed and diluted in 
RPMI1640 + 5% FBS to reach the desired MOI. 
2.2.5. Titration of bacterial stocks 
To determine the appropriate amount of bacterial suspension to reach a MOI 
of 1 (one inclusion-forming unit (IFU) per cell) freshly prepared stocks of Simkania 
negevensis were titrated. Therefore HeLa 229 cells were seeded in 24-well plates on 
glass cover slips, the next day, were infected with different dilutions of the bacterial 
suspension, as described before. The cells were fixed after 72 hpi, with 4% PFA in 
PBS for 20 min at RT, washed twice with PBS and taken up for immunostaining.The 
cells were permeabilised with 0.2% Triton X 100 for 20 min. To prevent unspecific 
binding of the antibody the cells were incubated in 2% FBS in PBS for 1 h at RT then 
incubated with a mouse anti-chlamydial heat shock protein 60 (cHsp60) (1:500) or Sn 
   79
antibody (1:50) in 2% FBS/PBS for 1 h at RT. Cells were washed thrice with PBS and 
incubated with a secondary Cy2TM-linked sheep anti-mouse antibody in 2% 
FBS/PBS. To counterstain nuclei, cells were incubated with Hoechst 33342 dye 
(Sigma) (1:3000) for 30 min at RT, washed twice with PBS, and mounted with Mowiol 
mounting medium (Table 2.4). Bacterial inclusions and cellular nuclei were counted in 
an epifluorescence microscope (Leica) with 40x fold magnification to calculate the 
concentration of the stocks. 
The MOI was calculated using the formula: 
IFU/ml= Number of inclusions in a 40X microscopic field X 1916.28 X dilution 
factor X 1 
The factor 1 is used if 1 ml of the media is used and if 500 µl is used the factor 2 is 
used for calculation MOI. 
2.2.6. Apoptosis induction 
To study if Sn could resist apoptotis, different apoptotic inducers like tumor 
necrosis factor α (TNF-α) applied together with cycloheximide (chx), required to 
prevent the survival pathway and staurosporine (STS) was used. After 3 dpi with Sn 
the media was removed and the cells were either treated with 20 ng/ml of TNF-α/3 
µg/ml of chx or 1 µM of STS in 500 μl fresh RPMI1640 + 5% FBS. These cells were 
incubated at 35°C for 4 h or 6 h respectively for TNF-α/chx and STS. 
2.2.7. Assays to measure apoptosis 
     2.2.7.1. Hoechst or DRAQ5 staining 
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Following the indicated treatment, cells were stained with 20 μM Hoechst 33258 or 
the far-red fluorescent DNA dye DRAQ5 at a dilution of 1:500 for 30 min at 37°C on 
glass slides. After fixing with 4% PFA, cells were stained and washed with PBS. 
Nuclear morphological changes (fragmentation or condensation) were determined 
under an epifluorescence microscope. At least 300 nuclei per sample were counted. 
     2.2.7.2. TUNEL assay 
Fragmentation of chromosome by endonucleases is a hallmark of the later 
stage of apoptosis that results in a multitude of 3’-hydroxyl termini of DNA ends.  This 
property can be used to identify apoptotic cells by labeling the DNA nicks with 
fluorescent-tagged deoxyuridine triphosphate nucleotides (F-dUTP). The enzyme 
terminal deoxynucleotidyl transferase (TdT) catalyzes a template-independent 
addition of deoxyribonucleoside triphosphates to the 3’ hydroxyl ends of double- or 
single-stranded DNA and generates DNA strands with exposed 3'-hydroxyl ends. 
Addition of the deoxythymidine analog 5-bromo-2'-deoxyuridine 5'-triphosphate 
(BrdUTP) to the TdT reaction serves to label the break sites. Once incorporated into 
the DNA, an anti-BrdU antibody using standard immune histochemical techniques 
can detect BrdU. Non-apoptotic cells do not incorporate the F-dUTP because of 
absence of exposed 3’-hydroxyl DNA ends. Hence, to detect a significant difference 
in apoptosis of infected versus non-infected cells, DNA fragmentation was determined 
by the terminal deoxynucleotidyl transferase (TdT) mediated dUTP-2 nick endlabeling 
(TUNEL) method using the Dead EndTM Fluorometric TUNEL Kit (Promega). This 
method allows for detection of apoptotic cells on single cell level (Gavrieli et al, 1992).  
Therefore, cells were seeded on glass cover slips, infected or mockinfected, and 
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treated with TNF-α/chx for 4 h. Cells were fixed with 4% PFA for 20 min at 35°C and 
labeled according to the manufacturer`s instructions. Briefly, cells were permeabilized 
with 0.2% [v/v] Triton X100 in PBS for 5 min, washed once with PBS, and stained with 
1 μg/ml Hoechst 33324 (1:3000) dye in PBS for 5 min. Cells were washed and 
permeabilized as above and equilibrated with equilibration buffer before incubation 
with the nucleotide mix and TdT enzyme for 1 h for 60 min at 37°C in a humidified 
chamber. The reaction was terminated with 2x SSC (saline sodium citrate). The cells 
were washed thrice and mounted with Mowiol. The ratio of TUNEL-positive cells was 
evaluated by counting five random fields in an epifluorescence microscope (Leica) 
with 40x fold magnification. 
     2.2.7.3. Luminescent caspases-8 activity assay 
The autoprocessing of procaspase-8 into its active form is a prerequisite for 
the apoptotic actions of the initiator caspase (Kang et al, 2008). To determine the 
activity of caspase-8 in Sn-infected TNF-α/chx treated cells, a luminescence based 
Caspase-Glo-8 Assay (Promega) was performed. This assay makes use of a 
substrate with a LETD sequence that was proposed to be specifically cleaved by 
caspase-8 (Thornberry et al, 1997). According to the instructions, 15,000 HeLa 229 
cells were seeded in a white flat bottom 96-well plate (Nunc) to reach about 70% 
confluency at the day of infection. Cells were treated as described above in a volume 
of 100 μl and the luminescent caspase-8 substrate was added 4 h after TNF-α/chx 
induction. The plate was shaken for 30 sec at 450 rpm with a Thermomixer 
(Eppendorf) and incubated for 75 min at RT in the dark. Subsequently, luminescence 
was measured in a plate reader (Tecan) with light exposure duration of 1 sec/well. 
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     2.2.7.4. Cytochrome c release 
The cells were infected and treated with TNF-α/chx induction as described 
above. After 4 h of induction the cells were fixed with 4% PFA and taken up for 
immunostaining with cytochrome c antibody. The absence of cytochrome c in the 
mitochondria indicated a loss of membrane potential. 
     2.2.7.5. Active caspase-3 staining 
The cells were infected and treated with TNF-α/chx induction as described 
above. After 4 h of induction the cells were fixed with 4% PFA and taken up for 
immunostaining with cleaved or active caspases-3 antibody. Uninfected cells induced 
with TNF-α/chx were taken as the positive control. Active Caspases-3 could be found 
on the surface of apoptotic cells. 
     2.2.7.6. Activation of Bax 
The cells were infected and treated with TNF-α/chx induction as described 
above. After 4 h of induction the cells were fixed with 4% PFA and taken up for 
immunostaining with active Bax antibody. Uninfected cells induced with TNF-α/chx 
were taken as the positive control. Active Bax could be found accumulated on the 
mitochondria in apoptotic cells. The cells were analyzed under confocal microscope. 
     2.2.7.7. Heterodimerisation of Bax and Bak 
Upon induction of apoptosis, Bax and Bak change their conformation and 
homo-oligomerize to permeabilize mitochondria (as described under 1.1.5.1.b). 
Hence it was necessary to investigate if Sn-infected cells upon apoptosis induction 
can prevent the oligomerisation of Bax and Bak. HeLa 229 cells were grown in 35 cm2 
plates to 60-70 % confluency. Apoptosis was induced as described above or mock 
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induced in the presence of 3 µg/ml cycloheximide. Supernatant was collected and the 
remaining cells were scraped with a rubber police and washed in PBS by 
centrifugation at 1,000 rpm for 3 min at 4°C. For mitochondrial isolation, the pellet was 
resuspended in Buffer A (20 mM Hepes pH 7.6, 220 mM mannitol, 70 mM sucrose, 1 
mM EDTA, 0.5 mM PMSF and 2 mg/ml BSA) and left on ice for 15 min. Cells were 
homogenized 20 strokes with a homogenizer and pelleted at 800 g for 5 min at 4°C. 
Mitochondria containing supernatant was collected and centrifuged again at 10,000 g 
for 10 min at 4°C. Mitochondrial pellet was resuspended in Buffer B (Buffer A without 
BSA), quantified using a Nanodrop (Peqlab, Germany) and stored at -80°C. 
Supernatant containing cytoplasmic proteins was kept in cytochrome c release 
assays. Mitochondria (60 µg) were pelleted (10,000 g, 10 min, 4°C) and washed once 
with SET-buffer (and resupended in 95 µl SET-buffer. Cross-linking was done with 
BMH (Pierce, Rockford) at a final concentration of 1 mM for 30 min at RT. For 
quenching of the cross linker 2 µl DTT (2.5 mM) were added and samples were 
incubated for 5-10 min on ice. Cross-linked mitochondria were pelleted (14,000 rpm, 
5 min, 4°C) and washed once in SET-buffer, resuspended in 30 µl Laemmli-buffer 
and analyzed by western blotting. 
2.2.8. Infectivity assays 
In order to investigate whether the production of simkanial progeny is altered 
by NF-кB activation, an infectivity assay was carried out. Therefore, bacterial 
inclusions were ruptured at the end of the developmental cycle and the particles were 
transferred to uninfected cells for a second round of infection. The primary infection is 
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described in section 2.2.3. At the end of the developmental cycle the inclusions were 
lysed by either incubating at -80°C for 1 h followed by incubation at 35°C and ruptured 
by pipetting the cells up and down or by glassbeads. Supernatant containing EB was 
transferred to freshly plated HeLa cells on glass cover slips in different dilutions. 
Infected cells were incubated for 72 h at 35°C and fixed in 4% PFA. Cells were 
stained for chlamydial Hsp60 and counterstained with Hoechst 33324 for DNA. 
2.2.9. Inhibitor treatment 
For inhibition of NF-кB activation, cells were treated with 25 μM Caffeic Acid 
Phenethyl Ester (CAPE) (Sigma) in DMSO in 500 µl of medium. Stock solution of 
CAPE was made by dissolving CAPE in DMSO to make 25 mM, hence1:1000 of 
stock (25 μM) was used in each experiment. CAPE is a cell permeable active 
component of propolis from honeybee hives, a potent and specific inhibitor of NF-кB 
activation. Control cells were treated with solvent alone. After 5 h of CAPE treatment 
the infected cells were induced with TNF-α/chx for apoptosis. This set up was also 
used for Sn for its effect on infection and infectivity. 
To inhibit the PI3 kinase, a cell permeable, potent and specific 
phosphatidylinositol 3- kinase inhibitor LY294002 (Calbiochem) was used. It acts by 
binding to the ATP binding site of the enzyme. Stock solution of the inhibitor was 
made in DMSO. LY294002 was used at varying concentration of 0.1,1 and 10 µM and 
the controls were treated with the solvent alone to investigate the importance of this 
survival signal in apoptosis resistance. 
2.2.10. Transfection 
   85
With the advent of RNA interference, the function of cellular proteins can be 
investigated by the delivery of small interfering RNAs (siRNAs) into the cells that then 
leads to the degradation of respective complementary mRNA transcripts (Elbashir et 
al, 2001). In order to deplete host cells of anti-apoptotic proteins, siRNA transfection 
was performed with LipofectamineTM 2000 (Invitrogen) or Polyethylenimine (PEI). 
     2.2.10.1. Polyethylenimine (PEI) transfection 
Cells (70-80 % confluence) were seeded one day before in 24 well cell 
culture plates. On the next day, cells were washed with PBS and incubated in 5% 
FCS medium immediately before transfection. About 1 μg DNA was prepared in 100 
μl Optimem transfection medium (GIBCO) for each sample and incubated at RT for 
10 min after vortexing. In the meantime, 0.9 mg/ml PEI was prepared in 100 µl 
optimum (Table 2.3). PEI was reported to have higher efficiency in forming complexes 
with nucleic acids and was better delivered into the cells, PEI also have reduced 
toxicity as it reduces free polycations in the transfection media (Godbey et al, 1999). 
The samples were vortexed and incubated at RT for another 20 min. The mixture was 
eventually added to the cells for transfection. The cell culture medium was replaced 
after 4-6 h with normal medium containing 10 % FCS. 
      2.2.10.2. LipofectamineTM 2000 DNA delivery (Invitrogen) 
In each transfection, the DNA (μg) and LipofectamineTM 2000 (μl) ratio was 
usually 1:2 to 1:3. One day before transfection, cells were seeded into 6-well plates to 
gain 70% confluency. 20 pM siRNAs were incubated in 200 μl Optimem transfection 
medium containing 4 μl LipofectamineTM 2000 for 25 min at RT before dropwise 
addition to 800 μl fresh RPMI medium containing 5% FBS. The media was removed 
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and replaced with 10% FCS media after 4-6 h. After 24 h post transfection, cells were 
infected with Simkania and experiments were performed as described before. 
2.2.12. Microscopy 
     2.2.12.1. Leica Fluoresence microscopy 
Nuclear fragmentation or condensation was detected by Leica DM RBE 
(Bensheim, Germany) fluorescence microscopy, following Hoechst staining as 
described in 2.2.7.1. 
     2.2.12.2. Confocal microscopy 
Confocal microscopes from DM1500 (Leica) was used in this study. Cells 
growing on a cover slip were washed and fixed, following the indicated treatment. 
After fixation, cells were permeabilized with PBS containing 0.2 % Triton X 100 for 30 
min. Before incubation with the primary antibody listed in Table 2.9 (1 h at RT), cells 
were blocked with 5 % FCS for 45 min. Cells were washed with PBS after incubation 
with the primary antibody, and further incubated with the corresponding secondary 
antibody (fluorescence conjugated) at RT for 1 h. Finally, cells were washed 3 times 
in PBS and once with distilled water to remove the PBS and mounted on a glass slide 
with Mowiol. Samples were kept at 4°C until analysis. Cells were inspected under 
laser scanning confocal microscope (Leica) with 60x fold magnification and an 
additional 1.5x software magnification. Images were further processed with the 
software Image J. 
     2.2.12.3. Electron microscopy (in collaboration with Prof. George Krohne)  
The HeLa 229 cells were infected either with Ctr or with Sn for 24 h or 72 h 
respectively. The infected cells were washed twice with PBS solution and fixed with 
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gluteraldehyde at 4oC for 1 hr. The fixed cells were washed with cocodylate buffer 
and taken for preparation of the sample. 
2.2.13. SDS-PAGE and Western blotting 
Protein levels or post-translational modifications such as phosphorylation 
were detected using the sodium-dodecylsulfate polyacrylamide electrophoresis (SDS-
PAGE). Gels of different density were prepared according to the table below. The 
proteins migrate in an electric field according to their size, which is mediated by SDS 
providing a uniform negative charge to the proteins. Different percentage of gels was 
used depending on the size of protein to be separated. 
Solution 
components for 
Separating gel 
6% 8% 10% 15% Solution components for 
Stacking gel 
(5%) 
H2O 5.3 4.6 4.0 2.3 6.8 
30% acrylamide mix 2.0 2.7 3.3 5.0 1.7 
1.5M Tris (pH 8.8) 2.5 2.5 2.5 2.5 1.0 M Tris (pH6.8) 
1.25 
10% SDS 0.1 0.1 0.1 0.1 0.1 
10% APS 0.1 0.1 0.1 0.1 0.1 
TEMED 0.008 
 
0.006 0.004 
 
0.004 
 
0.01 
Table 2.11. Components of SDS PAGE. 
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Following the indicated treatment, the cells were transferred to ice, the 
medium with detached cells was collected, and the adherent cells were directly lysed 
in 100 μl 2x Laemmli buffer. The lysates were then combined with the pellet of the 
respective detached cells after centrifugation at 4°C for 5 min at 350 x g and were 
heated to 95°C for 5 min. For phosphoproteins, lysis buffer containing phosphatase 
inhibitors was used (see Table 2.5) pipetting up and down, and transferred to a 
reaction tube (Eppendorf). Cell debris was removed by centrifugation for 5 min at 
13,000g and 4°C. The supernatant was transferred to a fresh tube and mixed with an 
equal volume of 2x Laemmli buffer. Lysates were heated to 95°C for 5 min and stored 
at -20oC until used. Denatured protein lysates were loaded onto the gels, besides the 
pre stained protein ladder (Fermentas, #SM0671). Gels were subjected to 80 volts for 
about 10-15 min until the proteins move into the separating gel, followed by a 
complete run at 120 volts for about 45-50 min. Subsequently, proteins were 
transferred to a methanol activated PVDF membrane (GE Healthcare) in a semidry 
electro blotting system (Thermo) with a current of 1.0 mA per cm2 membrane for 2 h. 
Membranes were rinsed in TBST20 (See Table 2.4) for 1 min before blocking the 
membrane for 1 h in blocking buffer to reduce unspecific binding of the antibody. The 
membrane was incubated with the respective primary antibodies listed in table 2.9, 
overnight at 4°C. After washing the membrane thrice for 10 min in TBST20, antibody-
antigen complexes were detected by respective HRP-linked donkey anti- rabbit or 
sheep anti-mouse secondary antibodies (GE Healthcare) listed in table 2.10. Further 
the blot was washed thrice 10 min each in TBST20 before developing in the x-ray filim 
(Konika Minolta) or in the developing machine (ChemoCam Imager INTAS). For re-
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probing with other antibodies, membranes were re-activated with 100% methanol and 
incubated in stripping buffer (Table 2.3) for 30 min at RT, after which the membrane 
was blocked for 1 h and then taken up for primary and secondary antibody for 
detection (as described above).  
2.2.14. EMSA (in collaboration with Dr. Bhupesh K Prusty) 
HeLa 229 cells were infected with Sn from day 1 to day 5; the infected cells 
with control were taken up for electro mobility shift assay. The cells were treated with 
ice cold hypotonic buffer containing (20 mM HEPES, 20% glycerol, 10 mM NaCl, 1.5 
mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 0.1% Triton X-100, 100 mM PMSF and 
cocktail of protease inhibitors). After 15 min incubation in ice, the lysates were 
centrifuged at 850g for 15 min at 40C. The supernatant which contain the cytoplasmic 
extract was removed and the pellet was washed with hypotonic buffer and treated 
with 2.5 times the pellet size of nuclear extraction buffer (20 mM HEPES, 25% 
glycerol, 500 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 0.1% Triton X-100, 
100 mM PMSF and cocktail of protease inhibitors) after 1 h the extraction mixture was 
centrifuged at 18000g for 15 min at 4oC. The supernatant was stored at -80o C. The 
oligo nucleotides described in materials were annealed and labeled with (γ32 P) ATP 
by T4 polynucleotide kinase and gel purified in 15% polyacrylamide gel. The binding 
reaction was performed in a 25 μl reaction mixture containing 50% glycerol, 60 mM 
HEPES, 20 mM HCl, 300 mM KCl, 5 mM EDTA, 5 mM DTT, 100 μg of BSA/ml, 2.5 μg 
of (poly dI-dC) and 10 μg of nuclear extract. After 5 min, 10,000 cpm of (γ32 P) ATP 5’ 
end labeled double stranded oligonucleotide probe was incubated for 25 min at RT. 
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The DNA protein complex was resolved in 4.5% non-denaturing PAGE dried and 
exposed to X-ray filims. 
2.2.15. RNA Isolation  
RNA isolation was performed for quantification of specific transcripts by 
quantitative reverse transcription polymerase chain reaction (qRT-PCR). HeLa cells in 
6-well plates were infected with Sn from day 1 to day 5. Cells were lysed in 1 ml 
TRIzol reagent (Invitrogen) per 6-well, transferred to reaction tubes (Eppendorf) and 
incubated for 5 min at RT. After addition of 0.2 ml chloroform, the samples were 
shaken, incubated for 5 min at RT, and centrifuged at 12,000g for 15 min at 4°C to 
separate RNA from DNA and proteins. The upper, aqueous phase containing RNA 
was transferred to a fresh tube and treated with 0.5 ml isopropyl alcohol to precipitate 
the RNA. Samples were incubated for 10 min at RT and centrifuged for 10 min as 
above. The RNA pellet was washed once with 1 ml 75% ethanol and centrifuged at 
7,500g for 5 min. The RNA pellet was air dried, dissolved in 50 μl DEPC H2O, and 
stored at -80°C until further use. 
2.2.16. DNA digestion  
In order to remove contaminating DNA from isolated RNA, DNA was digested 
with the TURBO DNAfreeTM Kit (Ambion). 5 μl TURBO DNase buffer and 1 μl DNase 
were added to 50 μl RNA sample and incubated at 37°C for 20 min. After addition of 5 
μl inactivation reagent, samples were mixed, incubated at RT for 5 min, and 
centrifuged at 10,000g for 15 min. The supernatant was transferred to a fresh reaction 
tube. 
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2.2.17. Copy (c) DNA synthesis  
For qRT-PCR, isolated mRNA was reverse transcribed into copy DNA 
(cDNA) with the Superscript VILOTM cDNA Synthesis Kit (Invitrogen) according to the 
manufacturer´s instructions. 4 μl 5 x VILO Reaction Mix and 2 μl enzyme Mix was 
added to 2 μg RNA and DEPC-H2O in a total volume of 20 μl. Reverse transcription 
into cDNA was performed in a thermocycler (GRI) with the following temperature 
profile: 10 min at 25°C, 60 min at 42°C, and 5 min at 85°C. Samples were stored at -
20°C until further use. 
2.2.18. Quantitative reverse transcription polymerase chain reaction (qRT-
PCR)  
To quantify the amount of specific mRNA populations, qRT‐PCR was 
performed. Amplification of cDNA and quantification of amplificates were performed in 
a Step One Plus RT PCR system (Applied Biosystems) using ABSolute Blue QPCR 
SYBR low ROX mix (Thermo) according to the manufacturer`s protocol: 0.1 μl of 
cDNA was mixed with 10 μl 2x ABSolute Blue QPCR SYBR low ROX mix, 125 nM of 
each primer (table 2.3), and ddH2O was added to a total volume of 20 μl. Each 
sample was analysed in triplicates. 
2.2.19. Statistical analysis 
Statistical significance of the acquired data was calculated with the two-sided 
Student´s T test. 
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3. Results 
3.1. Establishing S negevensis infection in cell cultures 
S. negevensis strain Z was obtained from ATCC (ATCC VR-1471T). The 
bacterium was cultivated as explained in the methods (2.2.3) and was titrated as 
explained in (2.2.4). HeLa 229 cells were plated in 12 well dishes with glass slides 
and were infected with Sn at a MOI of 1. After 72 hpi the cells were observed under 
light microscope. The cells were filled with tar like patches mostly in the perinuclear 
region in the cytoplasm. With increasing time of infection these patches extended and 
occupied a large proportion of the cytoplasm. At later time, some so called ‘inclusions’ 
looked empty, however when observed under phase contrast microscope fine rapidly 
moving particles could be observed. The cells were attached and still harbored the 
bacteria until 5 dpi, after which the cells were lysed and the bacterial particles were 
released into the medium. At a lower MOI the infection could proceed to nearly 8 days 
until the cells lysed as observed by (Kahane et al, 2002). The cells in later stages of 
infection looked more flat and expanded in morphology. It was also noticable that they 
stopped dividing as soon as they were infected and a visible inclusion could be seen. 
An electron microscopy of the Sn infected cells is shown in Figure 3.1b. All the cells 
that were tested were infectable with Sn (Figure 3.1a). 
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3.7a, 3.7b). Failure to release cytochrome c indicated incomplete activation of Bax 
and/or Bak upon apoptosis induction. Bax, once activated undergoes a 
conformational change permitting insertion into the mitochondrial membranes. First, it 
was excluded that either Bax or Bak are differentially transcribed during infection 
(data not shown). Then whether Bax translocation into mitochondria is affected in Sn-
infected cells upon TNF-α/chx -induced apoptosis was tested. Immunostaining 
confirmed strongly reduced levels of translocated Bax in infected cells upon apoptosis 
induction (Fig. 3.7d). Once activated Bax and Bak form oligomers in the mitochondrial 
outer membrane leading to the release of pro-apoptotic factors like cytochrome c.  
Bax and Bak oligomerisation was done via mitochondria isolation and in vitro cross-
linking using BMH (as decribed in methods 2.2.7.7). Neither Bax nor Bak were found 
to form oligomers after TNF-α/chx treatment in Simkania-infected cells in comparison 
to non-infected cells (Fig. 3.7c). Thus, Simkania infection inhibits Bax translocation to 
the mitochondria as well as Bax/Bak oligomerisation. 
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Figure 3.9. Immunoblot analysis of the anti-apoptotic/pro-survival signaling during Simkania infection. 
HeLa cells were infected with Simkania or Mock (control) in a time course experiment before analysis. 
Anti-apoptotic Bcl-2 family members like Mcl-1 or Bcl-2 (grey arrowheads) are not regulated. Akt is 
strongly activated during infection (black arrowheads). Hsp 60 and Actin (white arrowheads) were used 
as loading controls. n = 2. 
3.10. NF-кB is activated upon Sn infection  
NF-кB comprises a family of highly regulated dimeric transcription factors that 
play a pivotal role in inflammatory responses and immunological reactions and are 
required for apoptosis resistance in C. pneumoniae infection (Paland et al., 2006). To 
test the relevance of NF-кB signaling in Simkania infection, the degradation of IкB-α 
after Simkania infection was tested. The HeLa cells infected with Sn for 72 h were 
induced with TNF-α in the absence of chx for time points, ranging from 5 min to 60 
min. The cells lysates were blotted and probed against IкB antibody, to find that IкB 
was degraded in induced cells. Surprisingly the uninduced Sn-infected (72 h) cells 
also lacked the expression of IкB, which is the clear indication that NF-кB is activated 
upon Sn infection (Figure 3.10a). 
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Figure 3.10c shows the EMSA result, which indicates that NF-кB gets activated, 
revealing increased binding of NF-кB to an oligonucleotide comprising an NF-кB 
consensus motif upon 48 hpi with Sn and it is the maximum at 72 hpi at which they 
resist apoptosis. At the later time point of 4 dpi, the activation clearly goes down. 
 
Figure 3. 10c. To confirm if NF-кB binds to the nucleus in infected cells, the HeLa 229 cells were 
infected with Sn from day 1 to day 5 and the cells were taken up for EMSA (in collaboration with Dr. 
Bhupesh K Prusty). The nuclear extract was made and incubated against radioactive labeled probes. 
The samples were run on 6 % PAGE and developed. EMSA clearly shows that NF-кB is activated 
upon infection with Sn, n=2 
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3.11. NF-κB activation is necessary for apoptosis resistance 
The next question that rose was if NF-кB activation was required for the 
apoptosis resistance in Sn-infected cells. HeLa 229 cells were plated and treated with 
NF-кB specific inhibitor CAPE, a cell permeable active component of propolis from 
honeybee hives.  
 
Figure 3.11a. Bar diagram showing the percentage of apoptotic cells. Sn infected HeLa 229 cells were 
treated with CAPE (NF-кB Inhibitor) on 3 dpi for 5h and induced with 20 ng/ml TNF-α/3 mg/ml chx or 
carrier for 4 h before analysis. The cells were fixed and stained for Hoechst, the apoptotic and healthy 
cells were counted under 40x magnification, five fields per sample, n = 2, Error bars = SE n = 2. 
The HeLa 229 cells were plated and treated with 25 µM of CAPE for 5 h after 
3 dpi with Sn infection and were induced for apoptosis using TNF-α and chx as 
described in Methods. After 4 h of induction the cells were harvested for 
immunoblotting for PARP cleavage (as shown in figure 3.11b). A similar experiment 
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was performed for immunofluorescence to access the percentage of apoptosis 
(Figure 3.11a). CAPE treatment led to decrease in apoptosis resistance and the 
infected cells were more sensitized to apoptosis than the untreated cells. 
 
Figure 3.11b. Immunoblot analysis of PARP cleavage in Simkania infected cells after treatment with 
NF-кB inhibitor. Simkania-infected HeLa 229 cells were treated with CAPE (NF-кB Inhibitor) on 3 dpi 
for 5 h and induced with 20 ng/ml TNF-α/3 µg/ml chx or carrier for 4 h before analysis. PARP cleavage 
was a measure of apoptosis sensitization. Treatment with 10 µM CAPE clearly sensitized infected cells 
to apoptosis. Hsp60 and Actin were used as loading controls.n = 2. 
 
Figure 3.11c. Immunofluorescence of samples treated as described in Figure 3.11b. Samples were 
stained with Hoechst (blue) and viewed under a fluorescence microscope for counting. Hoechst dye 
stained both HeLa cell nuclei and Simkania inclusions. White arrowheads mark example apoptotic 
cells, n = 2. 
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3.12. NF-кB mutation affects the infectivity of Sn 
As NF-кB was strongly activated during infection it was interesting to check 
whether NF-кB activation is required for the development of bacterial inclusion and 
infectivity.  
 
Figure 3.12a. Bar diagram showing the Simkania infectivity assay. HT1080 wild type (fibrosarcoma 
cells) and IкB mutant cells were infected with Simkania at a MOI 1 for 3 days titrated on fresh HeLa 
monolayers and stained. Simkania positive cells were counted to determine differences in primary 
infection between the two cell lines (40x magnification, five fields per sample, n=2, Error bars = SE). 
Bacterial growth was strongly reduced in IкB mutant cells.  
Since the developmental cycle of Sn takes 3-5 days, inhibitor treatment was 
not feasible for this experiment due to toxicity upon long-term treatments. Therefore 
HT1080 cell line, which expresses a non-degradable IкB derivative, which sequesters 
NF-кB p65 in the cytosol, was used (Wang et al., 1996).  
   119
 
Figure 3.12b. Immunofluorescence analysis of HT1080 wt and IкB mutant cells infected with Sn. the 
cells are stained with Draq5 (blue) and with Sn antibody (red). The HT1080 WT cells are stained more 
with Sn than the IкB mutant cells showing that the mutants have defect in promoting Sn infection, n=3 
The cells were infected with Sn and taken up for infectivity assay. After 72 
hpi, the infected cells were lysed using glass beads or freeze thawing at -80oC. The 
lysate was used to infect freshly plated HeLa cells in different dilutions. After second 
round of infection for 72 h the cells were fixed with 4% PFA and stained with Hoechst 
and taken up for microscopy. The percentage of infected cells were calculated and 
used for making the graph as represented in Figure 3.12a. Surprisingly, the 
expression of non-degradable IкB resulted in decreased infection and infectivity in Sn 
(Fig. 3.12a), suggesting a role of NF-κB transcribed genes in the replication of Sn.  
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3.14. Activation of PI3 kinase pathway is required for apoptosis inhibition in 
Sninfected cells 
As PI3 kinase is a major survival signal, it was important to find if its activation 
is necessary for the resistance to apoptosis. To test whether activation of Akt is 
required for apoptosis inhibition, inhibitor experiments were performed. The Akt 
pathway was investigated by blocking the upstream activator phosphatidylinositol 3-
kinase (PI3K) using LY-294002 (Vlahos et al, 1994). The inhibitor is cell permeable 
and binds directly to the ATP binding site of the enzyme. 
Treatment of infected HeLa cells (3 dpi, MOI 1) with LY-294002 (dilution 
described in 2.2.9) for 2 h before induction of apoptosis resulted in a marked dose-
dependent apoptosis sensitization (Figure 3.14a) as judged from PARP cleavage and 
apoptotic cell count.  Different dilutions of the inhibitor were tested to find that the 
effect is gradual and not an artifact. These results show that the activity of Akt is 
required in Simkania-infected cells to resist apoptosis induction. Different dilutions 
ranging from 0.1, 1.0 and 10 µM were tested and the percentage of apoptotic cells 
rose gradually from 14.7 % to 46% and 66% respectively. This data clearly state that 
PI3 kinase signaling pathway is necessary to block resistance in Sn-infected cells. 
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Figure 3.14a. Immunoblot analysis of PARP cleavage in Simkania-infected cells after treatment with 
PI3K inhibitor. Simkania- infected HeLa 229 cells were treated with Ly294002 (PI3 kinase Inhibitor) on 
3 dpi for 2 h and induced with 20 ng/ml TNF-α/3 µg/ml chx or carrier for 4 h before analysis. PARP 
cleavage was ameasure of apoptosis sensitization. Treatment with 0.1 mM LY29004 clearly sensitized 
infected cells to apoptosis. Hsp 60 and Actin were used as loading controls, n = 2. 
 
Figure 3.14b. Bar diagram showing samples treated similar as in Figure 3.14a but prepared for 
immunofluorescence analysis. Hoechst stained cells were counted to determine the number of 
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apoptotic cells (40x magnification, five fields per sample, n = 2, Error bars = SE). 1 mM LY29004 was 
found to restore apoptosis sensitivity to 70% of control.  
 
Figure 3.14c. Immunofluorescence of samples treated as described in Figure 3.14b. Samples were 
stained with Hoechst (blue) and viewed under a epifluorescence microscope for counting. Hoechst dye 
stained both HeLa cell nuclei andSimkania inclusions. White arrowheads mark example apoptotic cells. 
White asticks mark the infected cells. n = 2. 
3.15. cIAPs are up-regulated and required for apoptosis resistance in Sn-
infected cells 
It is already reported that Inhibitor of apoptosis proteins (IAPs) plays a vital 
role in apoptosis inhibition of C. pneumoniae and C. trachomatis-infected cells 
(Paland et al, 2006a; Rajalingam et al, 2006b). Hence, the regulation of IAPs in Sn 
infected cells was under investigation. Interestingly in a time course western blot of 
the infected sample we found that cIAP-1 and cIAP-2 were up regulated in the course 
of infection (Figure 3.15a).  
   124
 
Figure.3.15a. Immunoblot analysis of theanti-apoptotic/pro-survival apoptosis regulators during 
Simkania infection. HeLa cells were infected with Simkania or Mock (control) (MOI 1) in a time-course 
experiment before analysis. Anti-apoptotic cIAP-1 and -2 (black arrowheads) are strongly upregulated. 
Hsp-60 and Actin (white arrowheads) were used as loading controls, n = 2. 
The up-regulation or stabilization was well pronounced after 48 hpi. Since the 
antibody against XIAP did not work, RT PCR was done to analyze the levels of XIAP 
mRNA over a time frame of infection. HeLa cells were infected with Sn for a time 
frame of day1 to day 5 and the RNA was isolated as explained above in methods 
2.2.15. The RNA was used for real time analysis of expression over time frame. The 
results show an up regulation of XIAP after 24 hpi. All this data explains how Sn 
resists apoptosis over a longer time period when compared to other Chlamydiales. 
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Figure 3.15b. HeLa 229 cells were infected with Sn for different days (1-5). The RNA from the cells 
was isolated as explained in methods. The RNA was converted into cDNA and taken for qRT-PCR to 
detect the relative amount of the targeted genes. Upon Sn infection the gene expression of cIAP-1 
(black) as well as XIAP (grey) was increased. The experiment was repeated three times to calculate 
the standard deviation.  
To prove, if these IAPs are required to maintain the high apoptosis resistance 
in infected cells. Expression of cIAP-1 and cIAP-2 was silenced in control and 
infected cells using specific siRNAs and induced with TNF-α/chx for apoptosis. 
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indicating the unfavorable condition for survival. Surprisingly as Figure 3.16 indicates 
the Sn infected cells could survive in the starving environment and continued in the 
proliferative and nourishing trophozoite form.The higher the MOI of Sn infection the 
better was the survival in the trophozoite form, indicating that Sn protects the 
amoeba to overcome unfavorable environment. 
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4. Discussion 
4.1. Resistance to apoptosis is highly conserved in the order Chlamydiales. 
Apoptosis resistance has been a common denominator as an outcome of 
infection and likely prerequisite for the development of obligate intracellular 
pathogenic Chlamydia. Here, in this study it is demonstrated that like other 
Chlamydiales, the evolutionary related bacterium Simkania negevensis is also able to 
block host cell apoptosis. Sn infection could block the apoptotic pathway at multiple 
levels by modulation of specific host cell factors. It is evident from the results 
described above that anti-apoptotic and survival mechanisms are widely conserved in 
the order Chlamydiales. Although the mechanisms involved is not completely 
revealed, the ability to replicate and maintain long-term relation in the host cell seems 
to significantly contribute to chlamydial pathogenicity. These intracellular parasites 
maintain a delicate balance between exploiting and protecting their host by hijacking 
the signaling pathways in the host cell. Interestingly these pathogens selectively, 
either up-regulate or stabilize the anti-apoptotic proteins and down-regulate or 
degrade the pro-apoptotic proteins by means of their proteases. Although 
Chlamydiales are known to resist apoptosis in the productive growth as a path of 
survival they are also known to inhibit apoptosis during persistent growth or in 
phagocytes but induce apoptosis in T cells, which indicates that modulating apoptotic 
pathways have an immunomodulatory role in chlamydial infections (Miyairi & Byrne, 
2006). An exception to this rule may be Parachlamydia, which appears to survive in 
human macrophages, but eventually triggers apoptosis (Greub et al, 2003). The 
inability to induce apoptosis inhibition may be one reason why Parachlamydia does 
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not replicate in most mammalian cell types (Matsuo et al, 2008). Interestingly 
Gimenez at al (2011) have reported about cross-talk between intra-amoeba 
pathogens. They could identify potential horizontal gene transfers between Legionella 
and Chlamydiales. But, it is still unclear whether Simkania and Parachlamydia are 
able to influence death of amoebae. The type 1 metacaspase in amoeba is known to 
regulate temperature fluctuations. At a lower temperature, metacaspase is over 
expressed and this induces the encystation of Acanthamoeba castellanii. This is 
associated with a reduced number of bacteria within amoeba (Ohno et al, 2008). 
Althought, metacaspases are already known for their role in PCD (Suarez et al, 2004) 
their natural substrate remained unknown until Sundstrom et al (2009), reported that 
tudor staphylococcal nuclease (TSN) is cleaved by metacaspases.  The human TSN 
is a substrate of caspase-3 during apoptosis; this impairs its ability to activate mRNA 
splicing and inhibits its ribonuclease activity. Sn infection could maintain the 
trophozoite form of the amoeba under starvation, which indicates that Sn could 
regulate some genes in amoeba for its survival and thus they successfully maintained 
a symbiotic association. Recently, Song et al (2012) reported that Atg-16 mediated 
autophagy is required for the encystment of Acanthamoeba castellanii. From this data 
one tempts to assume that Sn infection might also interfere with autophagy, since it is 
an innate immune mechanism employed by the host cell to clear infection. Sn 
infection might prevent autophagy and thus hinter the encystment of amoeba. This 
indicate that Sn have derived its ability to resist apoptosis as well as to evade 
autophagy, by co-evolving in amoeba. Signaling to cell death inhibition initially could 
have co-evolved as a consequence of the Simkania-amoebae interaction and could 
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have later been exploited during the exposure to mammalian cells. Adaptation to 
different hosts may, at least in part, explain the differences we observed in anti-
apoptotic signaling between cells infected with members of Chlamydiales adapted to 
amoebae (Simkania) and mammalian cells (C. trachomatis, C.pneumoniae). 
4.2. Sn resists apoptosis in infected cells in a time and MOI-dependent manner 
The apoptosis inhibition in Chlamydiales depends on its developmental cycle, 
with the onset early after EB to RB transition and maximum during RB replication 
(Fan et al, 1998a). The developmental cycle of Simkania lasts up to 10 days and 
therefore significantly longer than that of C. trachomatis (48 h) and C. pneumoniae 
(72–96 h) under comparable infection conditions. It was therefore unexpected to see 
that even at a MOI of 0.5, conditions, where hardly one EB infects one cell; about 
50% of the cell were protected from apoptotic stimuli already at 24 hpi and almost all 
infected cells were completely protected at 3 dpi. A similar efficient protection at such 
low MOI has neither been observed with C. trachomatis (Fan et al, 1998a) nor with C. 
pneumonia (Fischer et al, 2001; Rajalingam et al, 2001b). The infected cell remained 
resistant for apoptotic stimuli up to 4 dpi indicating that Simkania has evolved highly 
efficient and long-lasting mechanisms to block host cell death, which is evident from 
the regulation of the survival factors throughout the completion of its life cycle. Similar 
to C. trachomatis infection, cells infected at higher MOI acquired apoptosis resistance 
earlier (Figure 3.3c.), which has been suggested to be dependent on the rapid entry 
of the bacteria into the replicative phase of the developmental cycle (Fan et al, 
1998a). Interestingly, similar as with C. trachomatis, infection with Simkania at a 
higher MOI up to 100 had no visible cytotoxic effect, whereas significant cytotoxicity 
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already starting at a MOI of 10 has been reported for C. pneumoniae infection 
(Rajalingam et al, 2001b). The infected cells blocks apoptosis even though bacteria 
were cultured in cycloheximide containing media (an inhibitor of host cell protein 
biosynthesis). However it was observed that block in upregulation of proteins like 
IAPs and inhibiting the activation of survival factors like NF-κB sensitized the infected 
cells to apoptosis. This indicates that host protein production is also required for 
imparting resistance. Different to what has been reported for C. trachomatis infected 
McCoy cells, Sn did not induce apoptosis in neighboring uninfected cells during any 
stage of the infection, excluding paracrine apoptosis induction (Schoier et al, 2001). 
Rather in Sn infection studies, only the non-infected cells tend to apoptosis upon 
induction, as the bacteria infects the cells asynchronously. 
4.3. Sn infection can resist apoptosis signaling upstream of mitochondria 
Despite differences in the kinetics of the onset, efficiency and duration of 
apoptosis resistance, all the above data demonstrate a block in apoptotic signaling at 
the extrinsic and intrinsic levels. The mechanism underlying apoptosis resistance in 
Simkania-infected cells may thus be very similar to those in cells infected with C. 
trachomatis and C. pneumoniae, in which apoptotic signaling via mitochondria is 
prevented (Fischer et al, 2004a; Rajalingam et al, 2008a). Sn may preserve the 
mitochondrial function and prevent mitochondrial cytochrome c release by three 
potential mechanisms. It can block the upstream steps that can perturb mitochondrial 
function.The degradation or down regulation of pro-apoptotic BH3-only proteins is one 
of the sensible ways. Similar to the report on C. trachomatis-infected cells 
(Rajalingam et al, 2008a), this complete and strong block of apoptotic signaling was 
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maintained in the infected cell despite of unchanged levels of BH3-only proteins.  In 
contrast, others have found that chlamydial protease-like activating factor (CPAF) 
was responsible for degradation of BH3-only proteins in cells infected with C. 
trachomatis, (Dong et al, 2005; Fischer et al, 2004b) indicating that depletion of BH3-
only proteins plays a role in blocking apoptosis upstream of the mitochondria in their 
infection setting. The second way is to up-regulate the expression of anti- apoptotic 
BH3-only proteins. The mitochondrial membrane proteins Bcl-2 or Bcl-2 like proteins 
are anti-apoptotic and are able to prevent cytochrome c release and caspase-3 
activation. But it is also reported that overexpression of Bcl-2 does not always protect 
from apoptosis induced by Fas cross-linking (Chiu et al, 1995; Scaffidi et al, 1998; 
Strasser et al, 1995). Overexpression of Bcl-xl protein levels failed to block apoptosis 
induced by TNF-α (Erhardt & Cooper, 1996). On examining the level of Bcl-2 in Sn 
infected cells, stabilization or up-regulation could not be observed. Hence it is not 
likely that host Bcl-2 or Bcl-2 like molecules solely mediates the Sn anti-apoptotic 
activity. As it was reported that Mcl-1plays a key role in resisting apoptosis in 
Chlamydia infected cells, it was interesting to check the regulation in Sn infection. 
Mcl-1 as one of the major inhibitors of Bak and Bax activation was neither 
upregulated nor stabilized in Sn infected cells. Since, Mcl-1 was not regulated upon 
infection, activation or oligomerisation of neither Bak nor Bax were found in Sn-
infected cell treated with TNF-α/chx and cytochromec was fully retained in the 
mitochondria of these cells, which explained an inactive caspase-9 after apoptosis 
induction. Third possibility of protecting the mitochondrial potential loss is the novel 
anti-apoptotic factors that could be released by the bacteria into the cytoplasm of the 
   135
host cells. As Sn anti-apoptotic activity is found to be MOI and time frame dependent, 
it becomes clear that Sn translation is important for the process. At a higher MOI the 
bacteria establish in the host much faster, meanwhile at a MOI of 1, by 72 hpi, the 
cells harbor visible inclusions hence; the maximum percentage of apoptosis inhibition 
was observed. Sn could harbor some mammalian anti-apoptotic protein homologues, 
which could prevent apoptosis as reported in the case of Epstein Barr virus. The 
BHRF1 in EBV are the homologues of mammalian Bcl-2, and it inhibits apoptosis 
induced by exogenous stimuli, like DNA damaging agents, the calcium ionophore 
ionomycin and the immunological apoptosis inducing molecules like TNF-α and Fas 
(Kelly et al, 2006). Another EBV nuclear antigen EBNA2 interferes with apoptosis 
induced by some stimuli through intrinsic pathway by sequestering Nur77 to the 
nucleus and preventing its translocation to the cytoplasm where it can induce 
cytochrome c release from the mitochondria (Lee et al, 2002). This indicates that the 
microbial homologues of apoptosis suppressors may be more potent than 
endogenous proteins. Currently it is not known which among the above-mentioned 
factors might be responsible for the mitochondrial signaling blockage in Sn-infected 
cells. Unlike in C. trachomatis infection, despite the fact that, the anti-apoptotic BH3-
only proteins are not regulated upon Sn infection, Sn can protect the cells from 
membrane permeabilisation and potential loss. Since Sn infection can prevent the 
caspase activation downstream of mitochondria, it becomes clear that regulation of 
signals upstream of mitochondria may not be the only mechanism employed by Sn to 
achieve the strong inhibition to apoptosis. 
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4.4. Caspases are differentially regulated upon Sn infection 
Caspases are regulated during pathogenesis in different ways. Legionella 
pneumophila activates Caspase-1 via flagellum and type IV secretions in response of 
host IPAF prevented phagosome maturation and led to clearance of infection (Amer 
et al, 2006). Regulation at the level of these cysteine proteases is critical for extrinsic 
as well as intrinsic apoptosis pathway. Caspases exist as zymogens are activated by 
cleavage, which permits their protease activity and degradation of substrates leading 
to cell death. Infection with any pathogen is recognized by the cells leads to the 
inflammatory responses and release of cytokines, which binds to its receptor and 
initiates the cascade of caspase activation. The resistance to apoptosis in Ctr was 
also accounted on the receptor shedding from the infected cells by activated 
metalloproteinase, TACE. But upon Sn infection as TNF-α induction lead to a strong 
downstream cascade of survival signals like MEK and ERK it was clear that the 
resistance to cell death is not contributed by TACE or other means that lead to 
reduced display of receptors on cell surface. Activated caspases lead to cell death 
thereby reducing the chance of pathogen to complete its life cycle. The baculovirus is 
known to inhibit all types of caspases by a baculoviral p35 protein, by cleaving the 
reactive site loop and forming a protease-inhibitor complex. In addition cowpox virus 
inhibits the active site of caspases by serine protease inhibitors. One of the most 
efficiently used methods by pathogens is to up regulate the cellular inhibitor of 
caspases, the IAPs. Upon Sn infection by one day of infection itself an upregulation of 
various IAPs could explain the reduced activation of caspases upon apoptosis 
induction. But in Sn-infected cells the caspases were differentially regulated. Upon Sn 
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infection, caspase-8 was activated but the executioner caspase -3 and -9 was 
prevented from activation upon induction with TNF-α. With the activation and 
recruitment of complex 1 (consisting of TNFR, TRADD, RIP1 TRAF2), the 
executioner, caspase-3 normally gets activated. This activation was blocked upon Sn 
infection, which indicates either the formation of complex 1 is affected or that some 
bacterial factors directly influence the caspase maturation downstream. The data 
presented here and the previously published work demonstrates that IAPs play a 
major role in maintaining apoptosis resistance in cultured cells infected with C. 
trachomatis and C. pneumonia (Rajalingam et al, 2006a). IAPs are important 
regulators of apoptosis that bind directly to caspase-3 and -9 with their BIR domain 
and thus block their activation. During Sn infection IAPs gets upregulated as shown in 
the figures, until the pathogen lyse the cells. Hence this could be a possible 
mechanism by which caspase activation is inhibited. But recently some reports have 
raised doubts over the ability of IAPs in directly inhibiting the catalytic activity of 
caspases (Eckelman & Salvesen, 2006). But, abrogation of IAPs using siRNA 
sensitizes the Sn infected cells to apoptosis. Hence analyzing the apoptosis pathway 
in IAP knockdown scenario could reveal the dependence of caspase activation on 
IAPs. However, recent data obtained in pulmonary infection experiments with C. 
pneumoniae in knockout mice suggest an important function of cIAP-1 in innate 
immune signaling in macrophages (Prakash et al, 2009). A role of IAPs in innate 
immune signaling is consistent with recent reports demonstrating a role of both, cIAP-
1 and cIAP-2 in innate immune signaling rather than in directly inhibiting caspase 
activation (Gyrd-Hansen & Meier, 2010). Infection may directly influence IAP stability 
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as these proteins possess E3 ligase activity and control their own stability and the 
stability of other IAPs (Vaux & Silke, 2005b). In this context the previous description 
of IAP-IAP hetero complexes implemented in IAP stabilization in C. trachomatis-
infected cells may also be relevant for Simkania infection (Rajalingam et al, 2006a). 
4.5. Caspase-8 is activated upon Sn infection 
Unlike other Chlamdiales, the caspase-8 was found to be activated even in 
the Sn infected cells without any apoptosis induction but still prevented cells death. 
During Sn infection the cells were maintained in RPMI containing 5% FCS and 1μg/ml 
of cycloheximide.  Addition of protein synthesis inhibitor reduces the synthesis of the 
cellular caspase-8 inhibitor, cFLIP, which leads to the accumulation of complex II to 
the TNFR and leading to caspase-8 activation. A death ligand association 
independent, activation of caspase-8 is also reported for the induction of autophagy 
(Laussmann et al, 2011), efficient ways of the host to eliminate pathogens by fusing 
with endosomes and lysosomes to finally degrade the sequestered material. However 
Sn should have strategies to modify this pathway as they survive in the host 
mysteriously. Meanwhile since autophagy is the major pathway for the turnover of 
cytoplasmic components like mitochondria, peroxisomes, smooth and rough 
membranes, proteins, lipids, RNA and lysosomes, Sn could also easily modulate 
autophagy to gain access to nutrients by autophagosomes into the inclusion.  
4.6. Akt is activated upon Sn infection 
As previously described for C. trachomatis (Verbeke et al, 2006) and C. 
pneumoniae (Coombes & Mahony, 2002) infection, Simkania infection strongly 
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activates the PI3K-Akt pathway. Activated Akt promotes cell survival through 
crosstalk with other signaling cascades like the NF-кB pathway (Romashkova & 
Makarov, 1999). Akt has in addition a role in cell survival by increasing the uptake of 
nutrients, positive regulation of metabolic pathways and maintenance of mitochondrial 
membrane potential (Plas & Thompson, 2005). There is also a direct link between Akt 
and cell survival by phosphorylating and inhibiting the function of pro-apoptotic Bad 
(Datta et al, 2000). Any change in the Akt-specific phosphorylation of sites S116 and 
S136 in Bad in the course of Simkania infection was not observed (data not shown), 
as has previously been described for C. trachomatis infection (Verbeke et al, 2006). 
The observation that PI3K inhibitors sensitize cells infected with C. trachomatis 
(Rajalingam et al, 2008a) or Simkania to apoptosis speaks in favor for an evolutionary 
conserved role of this central survival pathway in controlling host cell survival during 
development and replication of Chlamydiales in their mammalian hosts. Activation of 
Akt can favor high expression of cIAP-1 (Gagnon et al, 2003), consistent with 
elevated levels of IAPs and increased phosphorylation of Akt during the course of 
infection until day 5. But it is still unknown about the mechanism that leads to 
persistent activation of Akt. An obvious reason could be that Sn secretes anti- 
apoptotic factors through their type III secretion apparatus as reported with other 
pathogens (Francois et al, 2000; Galan & Collmer, 1999; Navarro et al, 2005; Yuk et 
al, 2000). Salmonella enterica secretes effector protein SopB to induce sustained 
activation of Akt (Knodler et al, 2005b). Concurrently host cell stress could also result 
in Akt activation. Signaling through Akt is known to play (Dimmeler et al, 1998) a key 
role in protecting cells from variety of toxic stresses (Cross et al, 1995; Dent et al, 
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2003). Obligate intracellular pathogens like Chlamydia is known to increase 
mitochondria metabolism and oxidative stress (Hatch, 1998; Ojcius et al, 1998). In 
cells exposed to oxidative stress down regulation of PI3K/Akt pathway results in high 
level of apoptosis (Taylor et al, 2005) and interestingly the oxidants stimulate Akt 
survival pathway (Klotz et al, 2000; Zhuang & Kochevar, 2003). Mechanical stress 
caused by growing inclusion could also induce phosphorylation of Akt in various cell 
types (Dimmeler et al, 1998; Kippenberger et al, 2005). Thus it is very well possible 
that Sn secretes effective proteins or the mechanical stress developed due to 
thedevelopment of inclusion could lead to this efficient survival signal, the necessity of 
which is evident from the fact that the treatment of Akt inhibitors in Sn infected cells 
leads to its sensitization. 
4.7. NF-кB is activated upon Sn infection  
The nuclear factor-kB family of transcription factors plays a central role in the 
host response to infection by microbial pathogens by orchestrating the innate and 
acquired host immune responses. Diverse signaling pathways that originate from 
many different cellular receptors and sensors activate the NF-кB proteins. Many 
successful pathogens have acquired sophisticated mechanism to regulate this 
pathway by deploying subversive proteins or hijacking the host-signaling molecule.As 
cellular immune receptors like Toll Like Receptor (TLRs), cytokine receptors and 
TNFRsignals via NF-кB after recognizing a variety of pathogen associated molecular 
patterns (PAMPs). Activation of NF-кB following infection is reported in various 
pathogens. NF-кB activation leads to the secretion of cytokines and chemokines, as a 
part of host defense response to trigger host innate immune response. On the other 
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hand the anti-apoptotic effect of NF-кB is thought to be beneficial for intracellular 
pathogen that depends on host cell survival (Wan & Lenardo, 2010).  
In Sn, biphasic activation of NF-кB could be observed, early phase of 
infection, shortly after adhesion of the bacteria a transient translocation of the p65 
component of NF-кB could be observed (data not shown). It is very likely that this first 
wave of transient activation is via TLR signaling. At a later time point an unknown 
factor that depends on bacterial replication induces continuous localization of p65 and 
permanent degradation or ubiquitination of IкB as well as the up-regulation of various 
anti-apoptotic genes. Hence, as discussed above this time resolved activation 
provides insight into two opposing effects of NF-кB activation, initially beneficial for 
the host via activation of innate immune response and later advantageous for the 
pathogen, likely being casually involved in anti-apoptotic host cell phenotype. This 
second wave of activation persisted for a longer time of 72h, atypical with normal cells 
but a hallmark of certain cancers (Courtois & Smahi, 2006). An important feature 
associated with activation of NF-кB is the anti-apoptotic phenotype which pathogens 
exploit to ensure the integrity of the infected cells. Sn infection promoted an up-
regulation of cIAP1/2 and XIAP during the same time point as the NF-кB activation. 
This supports how the pathogen benefits, particularly because unlike other 
intracellular pathogens Sn needs nearly 5 days or more to complete its life cycle.  
Various pathogen factors have been reported for the NF-кB regulation, like 
sdbA and lubX mutants failed to elicit constitutive NF-кB activation and also exhibited 
severe growth defects in L. pneumophila (Bartfeld et al, 2009). Later the LegK1 
protein was recognized as the direct activator of NF-кB signaling. The pathogens 
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could target the host ubiquitinylation machinery, which plays a central role. Most of 
the effector proteins are primarily delivered through the type III secretion system as in 
Yersinia spp, or by type IV secretion system as in Bartonella spp. The YopJ/P protein 
of Yersinia block the NF-кB pathway by blocking the pro-inflammatory cytokines, 
recognized later as cysteine proteases they also have a deubiquitylating and 
desumoylating activity, which prevents the ubiquitination of IkB (Viboud & Bliska, 
2005). In the case of Salmonella spp. AvrA and SseL inhibits deubiquitylation of IkB. 
While the intracellular bacterial pathogen Chlamydia trachomatis inhibits NF-кB 
translocation by Rel-A degradation by the Chlamydia specific proteases CT441 (Lad 
et al, 2007), and chlamydial protease-like activating factor (CPAF) (Christian et al, 
2010). The chlamydial deubiquitylase and deneddylase (ChlaDub) binds to IκB and 
prevents its degradation (Le Negrate et al, 2008). While Chlamydia pneumoniae, 
which lacks ChlaDub, uses an inclusion specific protein encoded by the locus 
CP0236 to sequester NF-кB activator, ACT1/CIKS, which regulate NF-кB (Wolf et al, 
2009). In Sn infection as the second wave of activation persist for a longer time it is 
very likely that an unknown bacterial protein is playing a crucial role. More 
interestingly, the NF-кB mutant cells showed a reduced infectivity of Sn as shown in 
the results. This indicates that some critical survival factor depending on NF-кB is 
necessary for Sn survival or that NF-кB regulates some cell surface receptors 
required for bacterial uptake. 
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Figure 4.17. Overview of anti-apoptotic mechanisms in Sn infected cells: Simkania micro-manage the 
host signaling circuitry to favor the continued survival of the pathogen. Inhibition of apoptosis could be 
achieved by several different mechanisms. The various survival pathways activated by Sn is shown by 
red arrows and the pathways that they block to prevent apoptosis is shown by black arrows with cross 
bars. The black arrows with no bars indicate the possible upstream signals that promote the survival 
signals in Sn-infected cells. The Sn infection activates survival signal Akt upon infection, which could 
lead to the activation of NF-κB. This could activate increased transcription of anti-apoptotic genes like 
IAPs. IAPs prevent the activation of caspases. Although the BH3 only proteins are not degraded upon 
infection, Sn prevents cytochrome c release from the infected cells which hinters the downstream 
activation of caspase-9 and effector caspase-3. Sn infection can also activate caspase-8 but do not 
activate the Bid cleavage and activation thereby protecting the mitochondria.  
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The figure 3.16 depicts the overall anti-apoptotic and survival signals 
generated upon Sn infection in cells. The survival signals are persistent throughout 
the infection.This raises the questions how these long-term signaling events are 
fueled even several days after the first interaction of the pathogen with the host cell. 
One could speculate that the bacterial factors play a crucial role in manipulating the 
host. Like other pathogenic members of the Chlamydiales, Simkania has a type III 
secretion system that may help to transport proteins across the inclusion membrane 
into the cytosol of the host. Secreted bacterial proteins may take over the pacemaker 
function in maintaining the host cell in a survival mode to guarantee such a long-term 
host-pathogen relation. 
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5. Outlook 
The present study was an attempt to investigate on the evolutionary 
conservation of cell death modulation in the Chlamydiales. The newly discovered 
member of Chlamydiales, Simkania negevensis was under study. Since this pathogen 
differ from other Chlamydiales in their time span to complete the life cycle, it was 
obviously interesting to find the survival signals that would play a role. The 
experiments in this direction revealed that the mechanism of cell death inhibition is 
highly conserved in the order Chlamydiales, but still differ from the other members. 
Meanwhile, the differential activation of caspases should be given special attention, 
as the activated caspases in Sn infected cell could reveal more about pathogenesis 
and authophagy during infection. It is indicated in this work that activates PI3 kinase 
could lead to persistant NF-кB activation, hence this needs further elucidation.It will 
be also interesting to investigate the possibility that strong and rather persistent 
activation of NF-кB could promote development of cancer. One another interesting 
fact that came across was the reduced infectivity in NF-кB mutant cells, investigation 
in this direction could reveal the factors that could be necessary for the survival or 
uptake of the bacteria. Special attention should be given to the yet to be published 
finding that, Sn resides in the endoplasmic reticulum (results from Dr. Mehlitz) unlike 
other Chlamydiales. This tempts one to think the mechanism that this pathogen would 
adapt to secrete its effector proteins across multi membranes. It would also be 
interesting to understand how this pathogen prevents endoplasmic recticulum stress 
induced cell death. Further studies on amoebae would reveal how this pathogen 
adapted itself for an obligate intracellular lifestyle and moreover, studies on 
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Dictyostelium discoidium, which could serve as a suitable model organism would 
reveal more hints on apoptosis, phagocytosis, endocytosis, membrane trafficking, 
vesicle sorting and pathogenesis. 
More than anything the effector proteins that might imitate anti apoptotic host 
proteins and the one that play a role in maintaining the pathogen as a native 
component in the cell is yet to be discovered. This study could be further expanded to 
mouse models, which could reveal how severe could be an acute infection; this could 
also answer how Sn remained as an emerging pathogen. A closer look into pathogen 
clearance would be interesting.  Since Sn and Cpn are known to occupy the same 
niche, it would be interesting to see how co-infection works. How the presence and 
development of one pathogen affects the other? Is there a mechanism of niche 
protection by these pathogens? Sn transcriptomics and metabolomics could also 
pave the way to find more interesting candidates that could play role in survival of the 
pathogen.  
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